{
  "meta": {
    "title": "Schizophrenia_Other_Primary_Psychotic_Disorders",
    "url": "https://brainandscalpel.vercel.app/schizophrenia-other-primary-psychotic-disorders-47f9c7d4.html",
    "scrapedAt": "2025-11-29T18:35:56.791Z"
  },
  "questions": [
    {
      "id": 38088,
      "choices": [
        {
          "id": 152115,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, 3</span></span></span></p>"
        },
        {
          "id": 152116,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 3</span></span></span></p>"
        },
        {
          "id": 152117,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2, 3</span></span></span></p>"
        },
        {
          "id": 152118,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4, 5</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old patient diagnosed with schizophrenia is being evaluated for a change in their medication regimen. The healthcare provider is considering various antipsychotic medications and wants to choose a typical (first generation) antipsychotic for this patient. Based on the medications listed, which of the following are classified as typical antipsychotics?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluphenazine</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risperidone</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pimozide</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aripiprazole</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Olanzapine</span></span></span></li>\r\n</ol>",
      "unique_key": "Q8080337",
      "question_audio": null,
      "question_video": null,
      "map_id": 23784,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 1, 3</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluphenazine and 3. Pimozide&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are typical <strong>antipsychotics.</strong><br />\r\n\tTypical antipsychotics, also known as <strong>first-generation antipsychotics,</strong> are <strong>older antipsychotic drugs</strong> that primarily <strong>work by blocking dopamine D2 receptors</strong>, which can be <strong>effective in treating positive symptoms of schizophrenia,</strong> such as delusions and hallucinations. However, they can have significant extrapyramidal side effects and tardive dyskinesia.<br />\r\n\tThe other drugs listed are considered atypical or second-generation antipsychotics:</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risperidone:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While risperidone is considered an <strong>atypical antipsychotic</strong>, it is known for its <strong>higher risk of extrapyramidal side effects</strong> among the atypical antipsychotics.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aripiprazole:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is an <strong>atypical antipsychotic</strong> with a <strong>unique mechanism of action</strong> as a dopamine partial agonist.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Olanzapine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is another <strong>atypical antipsychotic</strong>, which <strong>has a lower risk of extrapyramidal side effects</strong>, although it carries a risk of metabolic side effects like weight gain and increased blood sugar levels.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/flow-chart-1.jpg\" style=\"height:402px; width:700px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 618.</span></strong></span></span></p>",
      "correct_choice_id": 152116,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8890,
      "choices": [
        {
          "id": 35527,
          "text": "<p>Comorbid depressive episode</p>"
        },
        {
          "id": 35528,
          "text": "<p>Comorbid substance abuse</p>"
        },
        {
          "id": 35529,
          "text": "<p>Female sex</p>"
        },
        {
          "id": 35530,
          "text": "<p>Poor social support</p>"
        }
      ],
      "text": "<p>A 24-year-old male patient with a 5-year history of schizophrenia is admitted to the emergency department after a suicide attempt. The patient has a history of auditory hallucinations, delusion of persecution, social withdrawal and had depressed mood, loss of interest, cannabis use and insomnia in the past few weeks. Which of the following factors is most closely associated with an increased risk of suicide in patients with schizophrenia?</p>",
      "unique_key": "Q9299525",
      "question_audio": null,
      "question_video": null,
      "map_id": 9135,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><strong>Ans. A) Comorbid depressive episode</strong></p><p><strong>&nbsp;</strong></p><p><strong>Option A:</strong></p><p>&nbsp;</p><p>Among the factors listed, a comorbid depressive episode is most closely associated with an increased risk of suicide in patients with schizophrenia. Depression is a significant risk factor for suicide in the general population, and this risk is compounded in individuals with schizophrenia, who may already have impaired judgment and reality testing due to their psychotic symptoms. The presence of depressive symptoms such as a depressed mood and loss of interest, as described in the patient's recent history, significantly elevates the risk of suicidal behavior.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Comorbid substance abuse</strong>: While substance abuse, including cannabis use as mentioned for this patient, is a risk factor for suicide and can exacerbate the course of schizophrenia, the presence of depressive symptoms is generally considered a more immediate and a more direct risk factor for suicide.</p><p>&nbsp;</p><p><strong>Option C. Female sex</strong>: In the general population, males are more likely to complete suicide, although females may attempt suicide more often. In the context of schizophrenia, the sex of the patient is less predictive of suicide risk compared to factors like depressive symptoms and substance abuse.</p><p>&nbsp;</p><p><strong>Option D. Poor social support</strong>: Poor social support is indeed a risk factor for suicide among patients with schizophrenia, but a comorbid depressive episode is often considered a more direct and immediate risk factor for suicide in these patients.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Suicide is the leading cause of premature death in patients with schizophrenia. Around 20-50% of patients with schizophrenia attempt suicide, and approximately 10% of patients with schizophrenia die by suicide. The factor which is most closely associated with suicide risk, would be a comorbid depressive episode.</p><p>&nbsp;</p><p><strong>Ref</strong>: Kaplan &amp; Sadockâ€™s Synopsis of Psychiatry, 12th edition, Page No 339.</p>",
      "correct_choice_id": 35527,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8878,
      "choices": [
        {
          "id": 35479,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Affective disturbances</span></span></span></p>"
        },
        {
          "id": 35480,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Association disturbances</span></span></span></p>"
        },
        {
          "id": 35481,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Avolition</span></span></span></p>"
        },
        {
          "id": 35482,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Autism</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A medical student is studying Bleuler&#39;s fundamental symptoms of schizophrenia. According to Bleuler, which of the following is NOT one of the four fundamental symptoms of schizophrenia?</span></span></span></p>",
      "unique_key": "Q9905287",
      "question_audio": null,
      "question_video": null,
      "map_id": 9123,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Avolition</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Eugen Bleuler</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, coined the term <strong>&quot;schizophrenia&quot;</strong> and described <strong>four fundamental symptoms of schizophrenia</strong>, also known as the <strong>&quot;4 A&#39;s,&quot;</strong> which are:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Autism:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This term, refers to <strong>withdrawn behavior where a patient is preoccupied with their thoughts</strong> and <strong>appears uninterested in external events</strong>. It should not be confused with the childhood disorder of &quot;autism.&quot;</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ambivalence:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This term refers to the <strong>inability to make decisions.</strong> Patients with ambivalence have difficulty deciding for or against something. For example, a patient with schizophrenia struggled to decide whether to put their foot forward or backwards while walking.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Affect disturbances:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This term refers to <strong>emotional disturbances, such as inappropriate affect</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Association disturbances:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This term refers to <strong>disturbances in the organization of thought, such as loosening of associations.</strong></span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In addition to primary symptoms, Bleuler also described secondary symptoms of schizophrenia, such as delusions and hallucinations.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Avolition is not one of the four A&rsquo;s of bleuler</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. It is a negative symptoms of schizophrenia, and has been defined as a loss of will or drive to indulge in goal-directed activities (such as grooming and hygiene, educational and occupational activities).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Eugene Bleuler gave 4 A&rsquo;s of Schizophrenia which are fundamental symptoms. They include:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-142637.jpg\" style=\"height:231px; width:600px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A Short Textbook of Psychiatry, 7th edition, Page No 55.</span></strong></span></span></p>",
      "correct_choice_id": 35481,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8880,
      "choices": [
        {
          "id": 35487,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asthenic</span></span></span></p>"
        },
        {
          "id": 35488,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Athletic</span></span></span></p>"
        },
        {
          "id": 35489,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyknic</span></span></span></p>"
        },
        {
          "id": 35490,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dysplastic</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kretschmer&#39;s body type theory suggests a correlation between certain body types and the predisposition to develop schizophrenia. Which body type, according to Kretschmer, is most associated with schizophrenia?</span></span></p>",
      "unique_key": "Q7064167",
      "question_audio": null,
      "question_video": null,
      "map_id": 9125,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Asthenic</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kretschmer&#39;s body type theory</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, proposed by <strong>German psychiatrist Ernst Kretschmer</strong> posited that there was a <strong>relationship between specific body types and the susceptibility to mental disorders,</strong> such as <strong>schizophrenia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asthenic:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>asthenic body type</strong> is characterized by <strong>being tall, thin, and having long limbs</strong>. According to Kretschmer, this body type is most closely associated with the development of schizophrenia.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Athletic:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The athletic body type is characterized by <strong>being muscular and well-proportioned</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Pyknic:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pyknic body type is characterized by a <strong>short, stocky build with a round body shape</strong>. Kretschmer proposed that individuals with this body type were more susceptible to developing bipolar disorders.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Dysplastic:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dysplastic body types are those that <strong>deviate from the typical body proportions, often due to genetic or environmental factors</strong>. Kretschmer did not specifically associate this body type with schizophrenia or other mental disorders.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kretschmer&#39;s body type theory&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">suggests that the <strong>asthenic body type is most associated with schizophrenia</strong>. However, it is essential to note that more recent research has not strongly supported these associations, and the role of body type in the development of mental disorders remains inconclusive.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A Short Textbook of Psychiatry, 7th edition, Page 393.</span></strong></span></span></p>",
      "correct_choice_id": 35487,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38174,
      "choices": [
        {
          "id": 152459,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous Lorazepam</span></span></span></p>"
        },
        {
          "id": 152460,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">ECT</span></span></span></p>"
        },
        {
          "id": 152461,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Olanzapine</span></span></span></p>"
        },
        {
          "id": 152462,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Escitalopram</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old woman is brought to the emergency room by her family because they have been unable to get her to eat or drink anything for the past 2 days. The patient, although awake, is completely unresponsive both vocally and nonverbally. She actively resists any attempt to be moved. Her family reports that during the previous 7 months she became increasingly withdrawn, socially isolated, and bizarre; often speaking to people no one else could see. Which of the following is the treatment of choice for the above condition?&nbsp;</span></span></span></p>",
      "unique_key": "Q2794766",
      "question_audio": null,
      "question_video": null,
      "map_id": 23870,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Intravenous Lorazepam</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation is suggestive of <strong>catatonia</strong>. Key features of catatonia include <strong>mutism</strong>, <strong>immobility</strong>, <strong>negativism</strong>, and <strong>waxy flexibility</strong> etc. The <strong>treatment of choice in this scenario is intravenous lorazepam</strong>. It can rapidly reduce the symptoms of catatonia in many cases and is considered a first-line treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Electroconvulsive Therapy (ECT):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ECT is a <strong>treatment of choice for catatonia</strong> that is <strong>refractory to benzodiazepines,</strong> but it is not typically the first-line treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Olanzapine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While olanzapine is <strong>effective in treating underlying psychotic disorders</strong>, it is <strong>not the first-line treatment for acute catatonic episodes</strong>. Infact, antipsychotics should be avoided in catatonic patients.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Escitalopram:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Escitalopram is <strong>primarily used for depression and anxiety disorders;</strong> it is not indicated in the acute management of catatonia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous lorazepam</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the <strong>first-line treatment for catatonia</strong>. <strong>Lorazepam</strong> acts by <strong>increasing GABAergic neurotransmission and reducing the levels of BDNF</strong>. It is <strong>effective</strong> in <strong>rapidly reducing the symptoms of catatonia</strong>, which can include <strong>mutism, immobility, and resistance to movement.</strong> Once the catatonic state is managed, further treatment should focus on the underlying psychiatric condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 11th edition, Page No 346.</span></strong></span></span></p>",
      "correct_choice_id": 152459,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8885,
      "choices": [
        {
          "id": 35507,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Turner syndrome</span></span></span></p>"
        },
        {
          "id": 35508,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Down syndrome</span></span></span></p>"
        },
        {
          "id": 35509,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DiGeorge syndrome</span></span></span></p>"
        },
        {
          "id": 35510,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Marfan syndrome</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 21-year-old male patient presents to the psychiatric clinic with symptoms of auditory hallucinations, the delusion of persecution, agitation and insomnia. During the initial evaluation, the clinician notes that the patient also has a history of recurrent infections, congenital heart defects, and hypocalcemia. The clinician suspects an association between the patient&#39;s psychiatric symptoms and an underlying genetic disorder. Which of the following genetic disorders is most likely associated with the patient&#39;s presentation?</span></span></p>",
      "unique_key": "Q1178372",
      "question_audio": null,
      "question_video": null,
      "map_id": 9130,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) DiGeorge syndrome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DiGeorge syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, also known as <strong>22q11.2 deletion syndrome</strong>, is a <strong>genetic disorder caused by a microdeletion of chromosome 22 at a location known as 22q11.2.</strong> This syndrome is characterized by a <strong>clinical triad that includes immunodeficiency, hypoparathyroidism, and congenital heart diseases</strong>. Individuals with DiGeorge syndrome are at an increased risk of developing psychiatric disorders, including schizophrenia (in 30% of cases), compared to the general population.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this case, the patient&#39;s presentation of<strong> hallucinations, delusions, and insomnia suggests a possible diagnosis of schizophrenia.</strong> The additional history of recurrent infections, congenital heart defects, and hypocalcemia further support the likelihood of an association with DiGeorge syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Turner syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, <strong>Option B. Down syndrome</strong> and <strong>Option D. Marfan syndrome</strong> are <strong>not specifically associated with an increased risk of schizophrenia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Numerous genes seem to be linked to the development of schizophrenia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, with <strong>nine specific genetic regions identified: 1q, 5q, 6p, 6q, 8p, 10p, 13q, 15q, and 22q.</strong> Notably, deletions on chromosome 22q11.2, known as 22q11 deletion syndrome or velocardiofacial syndrome (also referred to as DiGeorge syndrome), have been connected to the onset of schizophrenia in approximately 30% of cases.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 361.</span></strong></span></span></p>",
      "correct_choice_id": 35509,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38178,
      "choices": [
        {
          "id": 152475,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clozapine</span></span></span></p>"
        },
        {
          "id": 152476,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Haloperidol decanoate</span></span></span></p>"
        },
        {
          "id": 152477,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chlorpromazine</span></span></span></p>"
        },
        {
          "id": 152478,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thioridazine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old man presents to the emergency department displaying disorganized behavior. He was discovered walking barefoot in the middle of the night. Upon admission to the psychiatric ward and initiation of antipsychotic therapy, his symptoms stabilized. A review of his medical records reveals a consistent pattern: he regularly discontinues his prescribed antipsychotic medications after discharge, leading to a relapse of symptoms within 6 months. To optimize his treatment and reduce the likelihood of noncompliance, which medication would be most appropriate for maintenance therapy?</span></span></p>",
      "unique_key": "Q1775457",
      "question_audio": null,
      "question_video": null,
      "map_id": 23874,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Haloperidol decanoate</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a <strong>long-acting injectable form</strong> of <strong>haloperidol</strong>, an <strong>antipsychotic</strong>. Given typically <strong>once in a month or fortnight</strong>, it&#39;s ideal for patients with medication noncompliance issues.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>patient&#39;s recurrent noncompliance with oral antipsychotic medications</strong> leading to <strong>frequent relapses</strong> indicates the need for a <strong>long-acting injectable (LAI) antipsychotic</strong>, which ensures consistent therapeutic levels of medication for extended periods.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Clozapine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is <strong>reserved for treatment-resistant schizophrenia</strong>. While effective, it is not a long-acting injectable.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Chlorpromazine and Option D. Thioridazine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both are <strong>oral typical antipsychotics</strong> and do not offer the advantage of extended dosing intervals like the long-acting injectables.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Depot antipsychotics (long-acting injectable antipsychotics) are indicated in patients with <strong>poor compliance</strong> to medications. The patients typically receive the <strong>intramuscular injections</strong> of antipsychotics once a month or once a fortnight. Intramuscular injection is given using the <strong>Z track technique</strong>. Long-acting injectable antipsychotics available are:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flupenthixol</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluphenazine</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Haloperidol&nbsp;</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pipotiazine&nbsp;</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zuclopenthixol</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risperdione</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Olanzapine</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paliperidone</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aripiprazole&nbsp;</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 67.</span></strong></span></span></p>",
      "correct_choice_id": 152476,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38187,
      "choices": [
        {
          "id": 152511,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It causes the highest weight gain amongst all antipsychotics.</span></span></span></p>"
        },
        {
          "id": 152512,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">WBC count of less than 3500/dL at the time of starting clozapine is a contraindication.</span></span></span></p>"
        },
        {
          "id": 152513,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blood levels of clozapine should be maintained &lt;350 ng/mL to avoid agranulocytosis.</span></span></span></p>"
        },
        {
          "id": 152514,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It should not be used along with carbamazepine.</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old female presents to the psychiatry clinic for a follow-up. She has a long-standing diagnosis of treatment-resistant schizophrenia and has been under various antipsychotic medications with suboptimal response and significant side effects. Due to the persistence and severity of her positive and negative symptoms, the consulting psychiatrist is considering clozapine. The resident doctor, wanting to ensure she understands the nuances of clozapine treatment, discusses with her attending physician about the drug&#39;s profile. The consultant asks the resident: &quot;Which of the following statements regarding clozapine is not true?&quot;</span></span></p>",
      "unique_key": "Q8249020",
      "question_audio": null,
      "question_video": null,
      "map_id": 23883,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Blood levels of clozapine should be maintained &lt;350 ng/mL to avoid agranulocytosis.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>False.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Clozapine-induced agranulocytosis</strong> is believed to be idiosyncratic and <strong>not directly dose-dependent.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clozapine&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>unique antipsychotic that&#39;s indicated for treatment-resistant schizophrenia</strong>. The main points regarding its use include:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: True.&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clozapine&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is known for <strong>causing significant weight gain</strong>, and among all <strong>antipsychotics</strong>, it is indeed most associated with this side effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B: True.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Clozapine carries a risk of agranulocytosis</strong>, a <strong>potentially life-threatening decrease in the number of white blood cells</strong>. As such, monitoring of white blood cell (WBC) counts is mandatory for patients on clozapine. A baseline WBC count below 3500/dL is considered a contraindication to initiate the drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D: True.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carbamazepine</strong>, an <strong>anticonvulsant,</strong> can cause a <strong>drop in WBC count</strong>. Given clozapine&#39;s risk of agranulocytosis, combining it with carbamazepine can further increase this risk.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clozapine is the drug of choice in treatment-resistant schizophrenia.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Contraindications for clozapine use include WBC&lt; 3500/dl, history of agranulocytosis on clozapine, or use of other bone marrow suppressants like carbamazepine</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-144608.jpg\" style=\"height:319px; width:700px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-144651.jpg\" style=\"height:169px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 222.</span></strong></span></span></p>",
      "correct_choice_id": 152513,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8883,
      "choices": [
        {
          "id": 35499,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients with schizophrenia are more likely to be born in late winter and spring.</span></span></span></p>"
        },
        {
          "id": 35500,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cannabis use can increase the risk of schizophrenia by as much as 40%.</span></span></span></p>"
        },
        {
          "id": 35501,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Advanced paternal age and urban upbringing are associated with an increased risk of schizophrenia.</span></span></span></p>"
        },
        {
          "id": 35502,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Migrants have an increased risk of developing schizophrenia, and the risk is higher for first-generation migrants than the second-generation migrants.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the statements are correct about schizophrenia, except:</span></span></p>",
      "unique_key": "Q7241044",
      "question_audio": null,
      "question_video": null,
      "map_id": 9128,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Migrants have an increased risk of developing schizophrenia, and the risk is higher for first-generation migrants than the second generation migrants.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Research has indicated that the likelihood of developing schizophrenia is higher among both first-generation and second-generation migrants</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (second-generation is at an even higher risk than the first-generation, hence statement D is incorrect), particularly among those who originate from countries with lower socioeconomic status and black individuals who relocate to societies that are predominantly white.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Patients with schizophrenia are more likely to be born in late winter and spring:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>correct</strong>. Schizophrenia patients are more likely born in late winter and spring, possibly due to respiratory infections like influenza occurring in autumn/winter increasing the risk. Maternal exposure to influenza during the second trimester is a suggested risk factor, and so is the maternal infection with rubella, but the evidence remains inconclusive.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cannabis use can increase the risk of schizophrenia by as much as 40%:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>correct</strong>. Cannabis use, especially heavy use and use from an early age, is associated with an increased risk of developing psychotic disorders including schizophrenia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Advanced paternal age and upbringing in urban areas are associated with an increased risk of schizophrenia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>correct</strong>. Advanced paternal age has been linked to an increased risk of several neurodevelopmental disorders, including schizophrenia. Similarly, being raised in an urban environment is associated with a higher risk of developing schizophrenia, likely due to factors such as increased stress, pollution, and higher population density.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Environmental factors associated with schizophrenia:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pre and perinatal complications.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> More likely</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Birth in late winter and spring.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> More likely. Hypothesis of maternal exposure to influenza and rubella.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Childhood risk factors</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- More likely to have poorer motor development, speech difficulties, delayed milestones and lower premorbid IQ.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immigrants</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (second-generation&gt;first-generation) are at higher risk</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urban birth and upbringing</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug abuse, especially cannabis</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Advanced paternal age</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 357-358.</span></strong></span></span></p>",
      "correct_choice_id": 35502,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8896,
      "choices": [
        {
          "id": 35551,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Switch to oral haloperidol</span></span></span></p>"
        },
        {
          "id": 35552,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administer intramuscular olanzapine</span></span></span></p>"
        },
        {
          "id": 35553,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administer intravenous lorazepam</span></span></span></p>"
        },
        {
          "id": 35554,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administer intramuscular promethazine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old male with a history of schizophrenia was brought by family members&nbsp; due to increased agitation and aggressive behavior. He was administered intramuscular haloperidol, in the emergency department for quick control of symptoms. Within an hour, the patient developed sustained upward deviation of the eyes. What is the next best step in the treatment of this patient?</span></span></p>",
      "unique_key": "Q5716860",
      "question_audio": null,
      "question_video": null,
      "map_id": 9141,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Administer intramuscular promethazine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient in this scenario has developed <strong><u>acute dystonia</u></strong> which is a <strong>side effect of the intramuscular haloperidol.</strong> <strong>Acute dystonia</strong> is characterized by <strong>sudden and involuntary muscle contractions</strong>. An <strong>oculogyric crisis</strong> is a <strong>specific type of acute dystonia that involves sustained upward deviation of the eyes</strong>. Acute dystonia is a more likely side effect of high-potency first-generation antipsychotics like haloperidol in comparison to second-generation antipsychotics. Also, its more like when antipsychotic is administered parenterally in comparison to oral use.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The next best step in <strong>treating this patient&#39;s acute dystonia is to administer intramuscular</strong> <strong>promethazine</strong>. <strong>Promethazine is an anticholinergic drug</strong>, which quickly <strong>reverses the symptoms of acute dystonia</strong>, including the oculogyric crisis. This intervention is typically effective within minutes and can be repeated if necessary.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Switch to oral haloperidol:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is <strong>incorrect</strong> because <strong>switching to oral haloperidol does not help with the immediate management of dystonia.</strong>&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Administer intramuscular olanzapine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is <strong>not appropriate</strong> because <strong>administering intramuscular olanzapine will not help with dystonia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Administer intravenous lorazepam:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>incorrect</strong> because, although <strong>lorazepam can help manage agitation, it is not the most appropriate treatment for acute dystonia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute dystonia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the <strong>earliest side effect </strong>of antipsychotics can be seen within minutes of receiving an injectable antipsychotic (also with oral antipsychotic). It is characterized by <strong>sudden contraction </strong>of a muscle group and can lead to symptoms like <strong>torticollis</strong> (twisting of the neck), <strong>oculogyric crisis</strong> (deviation of eyeballs), <strong>opisthotonos</strong> (extreme arching of the back), trismus (contraction of jaw muscles) or other dystonic reactions. Treatment of acute dystonia involves immediate administration of parental <strong>anticholinergics</strong> such as benztropine, promethazine, or diphenhydramine. To prevent acute dystonia, prophylactic use of oral anticholinergics is suggested while prescribing typical antipsychotics.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</span></strong></span></span></p>",
      "correct_choice_id": 35554,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8884,
      "choices": [
        {
          "id": 35503,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monozygotic twins have a lower concordance rate for schizophrenia than dizygotic twins.</span></span></span></p>"
        },
        {
          "id": 35504,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monozygotic twins have a similar concordance rate for schizophrenia as dizygotic twins.</span></span></span></p>"
        },
        {
          "id": 35505,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monozygotic twins have a higher concordance rate for schizophrenia than dizygotic twins.</span></span></span></p>"
        },
        {
          "id": 35506,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is no significant difference in concordance rates for schizophrenia between monozygotic and dizygotic twins.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In twin studies, which of the following statements best describes the concordance rate for schizophrenia in monozygotic and dizygotic twins?</span></span></p>",
      "unique_key": "Q4691064",
      "question_audio": null,
      "question_video": null,
      "map_id": 9129,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Monozygotic twins have a higher concordance rate for schizophrenia than dizygotic twins.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Studies have found that <strong>monozygotic twins have a higher concordance rate for schizophrenia than dizygotic twins.</strong> The concordance rate refers to the likelihood that both twins will develop schizophrenia if one of them has the disorder. <strong>Monozygotic twin studies have shown concordance rates for schizophrenia ranging from 40-65%,</strong> whereas <strong>dizygotic twin studies have reported rates of around 10-20%.</strong> This discrepancy in concordance rates provides support for the theory that genetic factors have a significant impact on the development of schizophrenia. However, the fact that the concordance rate for monozygotic twins is not 100% suggests that environmental factors also contribute to the etiology of the disorder.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>incorrect</strong> as <strong>monozygotic twins have a higher, not lower</strong>, <strong>concordance rate</strong> for schizophrenia compared to dizygotic twins.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B</strong>. This statement is <strong>incorrect</strong> as there is a <strong>significant difference in concordance rates</strong>, with <strong>monozygotic twins having a higher rate</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D.&nbsp;</strong>This statement is <strong>incorrect</strong> as studies do show a significant difference in concordance rates, with <strong>monozygotic twins having a higher concordance rate for schizophrenia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-142816.jpg\" style=\"height:271px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 360-361.</span></strong></span></span></p>",
      "correct_choice_id": 35505,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8894,
      "choices": [
        {
          "id": 35543,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Typical antipsychotics primarily target dopamine D2 receptors, while atypical antipsychotics target both dopamine D2 and serotonin 5-HT2A receptors.</span></span></span></p>"
        },
        {
          "id": 35544,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atypical antipsychotics generally have a lower risk of extrapyramidal side effects compared to typical antipsychotics.</span></span></span></p>"
        },
        {
          "id": 35545,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atypical antipsychotics are more effective in treating negative symptoms of schizophrenia than typical antipsychotics.</span></span></span></p>"
        },
        {
          "id": 35546,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Typical antipsychotics have a higher risk of causing metabolic side effects compared to atypical antipsychotics.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about the differences between typical and atypical antipsychotics is NOT true?</span></span></p>",
      "unique_key": "Q6858421",
      "question_audio": null,
      "question_video": null,
      "map_id": 9139,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Typical antipsychotics have a higher risk of causing metabolic side effects compared to atypical antipsychotics.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>NOT true</strong>. <strong>Atypical antipsychotics</strong>, rather than typical ones, <strong>have a higher risk of causing metabolic side effects</strong>, such as <strong>weight gain, dyslipidemia, and increased risk of diabetes.</strong> This is due to their complex interaction with various neurotransmitter systems, including histamine and muscarinic receptors, which contribute to these side effects. Therefore, patients taking atypical antipsychotics should be monitored for these metabolic side effects during treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Typical and atypical antipsychotics differ in their mechanism of action</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, side effect profiles, and effectiveness in treating various symptoms of schizophrenia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>true</strong>. <strong>Typical antipsychotics primarily target dopamine D2 receptors</strong>, which helps <strong>treat positive symptoms of schizophrenia</strong>, such as hallucinations and delusions. Atypical antipsychotics, on the other hand, target both dopamine D2 and serotonin 5-HT2A receptors. This broader mechanism of action allows atypical antipsychotics to address both positive and negative symptoms of schizophrenia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is also <strong>true</strong>. <strong>Atypical antipsychotics</strong> have a <strong>lower risk of causing extrapyramidal side effects</strong> (EPS), such as tardive dyskinesia, dystonia, and drug induced parkinsonism, compared to typical antipsychotics. This is one of the main reasons why atypical antipsychotics are generally preferred over typical antipsychotics as the first line treatment of schizophrenia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>true as well</strong>. <strong>Atypical antipsychotics</strong> are more <strong>effective in treating negative symptoms of schizophrenia</strong>, such as apathy, anhedonia, and affective flattening, compared to typical antipsychotics. The effectiveness of atypical antipsychotics in treating negative symptoms of schizophrenia is believed to be mediated by their action on both dopamine and serotonin receptors. Specifically, the antagonism of serotonin 5-HT2A receptors is thought to play a significant role in improving negative symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The exact mechanism is not fully understood, but it is hypothesized that the blockade of 5-HT2A receptors leads to an increase in dopamine release in certain brain regions, such as the prefrontal cortex. This increase in dopamine can help alleviate negative symptoms, as they are often associated with reduced dopaminergic activity in the prefrontal cortex. Remember, decreased dopamine activity in mesocortical pathway is responsible for negative symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">â€‹â€‹Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atypical antipsychotics&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are associated with a <strong>higher risk of metabolic side effects</strong>, <strong>including weight gain, diabetes, and dyslipidemia</strong>, compared to <strong>typical antipsychotics</strong>. This is contrary to the misconception that typical antipsychotics carry a higher risk of such side effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PATHOPHYSIOLOGY OF ANTIPSYCHOTIC INDUCED WEIGHT GAIN</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/flow-chart-2.jpg\" style=\"height:445px; width:600px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 123.</span></strong></span></span></p>",
      "correct_choice_id": 35546,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8899,
      "choices": [
        {
          "id": 35563,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kidney function tests</span></span></span></p>"
        },
        {
          "id": 35564,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroid function tests</span></span></span></p>"
        },
        {
          "id": 35565,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum creatine kinase level</span></span></span></p>"
        },
        {
          "id": 35566,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver function tests</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old male with a history of schizophrenia was recently started on haloperidol for treatment of his psychotic symptoms. Three days after starting the medication, he presents to the emergency room with fever&nbsp; (104&deg;F), diaphoresis, tachycardia, muscle rigidity, and altered sensorium. What is the most appropriate next investigation?</span></span></p>",
      "unique_key": "Q3695630",
      "question_audio": null,
      "question_video": null,
      "map_id": 9144,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Serum creatine kinase level</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of a <strong>patient presenting with fever, muscle rigidity, altered mental status, and autonomic instability</strong> after starting an <strong>antipsychotic medication</strong>, the most appropriate next investigation is <strong>serum creatine kinase (CK) level</strong>. These symptoms are suggestive of <strong>Neuroleptic Malignant Syndrome</strong> (NMS).&nbsp; <strong>Elevated CK levels</strong> are often seen in <strong>NMS due to rhabdomyolysis</strong>, which can also <strong>lead to acute kidney injury</strong>. Monitoring CK levels can help confirm the diagnosis, track the progression or resolution of NMS, and assess the risk of renal complications.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Kidney function tests:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While kidney function tests, such as <strong>blood urea nitrogen</strong> (BUN) and <strong>creatinine</strong>, are important in evaluating a patient&#39;s overall condition and potential renal complications, they are <strong>not specific for diagnosing NMS</strong>. However, these tests should be performed in conjunction with CK levels to monitor kidney function.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Thyroid function tests:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although thyroid dysfunction can <strong>present with altered mental status and autonomic instability</strong>, the <strong>presence of fever and muscle rigidity in this case strongly suggests NMS</strong>. Thyroid function tests may be considered in the differential diagnosis, but they are <strong>not the priority investigation</strong> in this specific clinical scenario.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Liver function tests:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver function tests can be <strong>deranged in NMS</strong>, but they are <strong>not specific for diagnosing NMS</strong>. They may be considered as part of a broader assessment, but CK levels should be prioritized in this case.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of a patient presenting with <strong>symptoms suggestive of Neuroleptic Malignant Syndrome</strong> (NMS) after <strong>starting an antipsychotic medication</strong>, the most appropriate <strong>initial investigation is the serum creatine kinase level</strong>. Elevated CK levels are indicative of muscle breakdown and are a key diagnostic feature of NMS.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 594-595.</span></strong></span></span></p>",
      "correct_choice_id": 35565,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8917,
      "choices": [
        {
          "id": 35635,
          "text": "<p><span style=\"font-size:12pt;\">Bipolar I Disorder, Current Episode Depressive with Psychotic Symptoms</span></p>"
        },
        {
          "id": 35636,
          "text": "<p><span style=\"font-size:12pt;\">Bipolar I Disorder, Current Episode Manic with Psychotic Symptoms</span></p>"
        },
        {
          "id": 35637,
          "text": "<p><span style=\"font-size:12pt;\">Schizophrenia</span></p>"
        },
        {
          "id": 35638,
          "text": "<p><span style=\"font-size:12.0pt;\">Schizoaffective Disorder</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 30-year-old woman presents to the psychiatric clinic with a 2-year history of mood episodes, including periods of elevated mood, grandiose ideas, increased energy levels, and decreased need for sleep, as well as episodes of depressed mood, lack of interest, insomnia and anhedonia. She has also experienced persistent auditory hallucinations and delusion of persecution during these mood episodes, and these symptoms have been present even during periods of euthymic mood. Currently, the patient reports experiencing a depressed mood, anhedonia, and persistent auditory hallucinations. Which of the following diagnoses is most appropriate for this patient?</span></p>",
      "unique_key": "Q8883920",
      "question_audio": null,
      "question_video": null,
      "map_id": 9158,
      "difficulty_level": "difficult",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Schizoaffective Disorder</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Schizoaffective Disorder</strong>&nbsp;is characterized by the <strong>concurrent presence of both mood disorder symptoms</strong> (either depressive or manic) and <strong>psychotic symptoms, such as hallucinations and delusions.</strong> The key feature that <strong>distinguishes schizoaffective disorder from bipolar disorder with psychotic symptoms</strong> is that the <strong>psychotic symptoms must be prominent and persistent</strong> for a <strong>significant portion of the total duration of the illness</strong>, and they must persist during periods when mood symptoms are absent or stable.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In this case, the <strong>patient experiences mood episodes consistent with bipolar disorder</strong> (periods of elevated mood, grandiose ideas, increased energy levels, and decreased need for sleep, as well as episodes of depressed mood, loss of interest and anhedonia.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">She also has persistent auditory hallucinations and delusion of persecution, even when there are no mood symptoms. Currently, the patient is experiencing a depressed mood, anhedonia, and persistent auditory hallucinations. <strong>This combination of mood and psychotic symptoms during both mood episodes and euthymic periods indicates that the most appropriate diagnosis Schizoaffective Disorder</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Bipolar I Disorder, Current Episode Depressive with Psychotic Symptoms:&nbsp;</strong>While the <strong>patient does have episodes of depression with psychotic symptoms</strong>, this diagnosis does <strong>not account for the psychotic symptoms</strong> occurring outside of the mood episodes.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B. Bipolar I Disorder, Current Episode Manic with Psychotic Symptoms:&nbsp;</strong>The patient is currently <strong>experiencing a depressive episode, not a manic episode</strong>, and the presence of psychotic symptoms outside of mood episodes is not accounted for by this diagnosis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Schizophrenia:&nbsp;</strong>While the <strong>patient has psychotic symptoms, the presence of significant mood episodes</strong> (both manic and depressive) that are a prominent part of the clinical picture suggests a diagnosis that incorporates both mood and psychotic features, which is more consistent with Schizoaffective Disorder.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Schizoaffective disorder</strong> is characterized by the <strong>presence of symptoms of both schizophrenia and mood disorder</strong>. Management of schizoaffective disorder include:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Schizoaffective disorder (bipolar type or manic type)-&nbsp; Use a combination of antipsychotics and mood stabilisers</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Schizoaffective disorder (depressive type)-&nbsp; Use a combination of antipsychotics and antidepressants</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Kaplan &amp; Sadockâ€™s Synopsis of Psychiatry, 12th edition, Page No 342.</strong></span></p>",
      "correct_choice_id": 35638,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8882,
      "choices": [
        {
          "id": 35495,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is equally prevalent in males and females</span></span></span></p>"
        },
        {
          "id": 35496,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The onset of schizophrenia is at a younger age in females than males</span></span></span></p>"
        },
        {
          "id": 35497,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Onset after 45 yrs of age is called &quot;Late-onset schizophrenia&quot;</span></span></span></p>"
        },
        {
          "id": 35498,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizophrenia is more prevalent in lower socioeconomic class</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the statements are correct about schizophrenia, except:</span></span></p>",
      "unique_key": "Q4926953",
      "question_audio": null,
      "question_video": null,
      "map_id": 9127,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) The onset of schizophrenia is at a younger age in females than males</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>onset of schizophrenia tends to occur at a younger age in males compared to females</strong>. Typically, <strong>males show the first signs of schizophrenia</strong> in their <strong>late teens to early 20s</strong>, whereas <strong>females tend to show symptoms in their late 20s to early 30s</strong>. There is also a second, smaller peak of onset in females after the age of 40, often referred to as late-onset schizophrenia, but the initial onset is generally earlier in males.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. It is equally prevalent in males and females:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>correct</strong>. Schizophrenia affects males and females with roughly equal prevalence, although the age of onset and symptom presentation can differ between genders.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Onset after 45 years of age is called &quot;Late-onset schizophrenia&quot;:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>correct</strong>. Schizophrenia that begins after the age of 45 is referred to as late-onset schizophrenia.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Schizophrenia is more prevalent in lower socioeconomic class:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>correct</strong>. Schizophrenia has been found to be more prevalent in <strong>lower socioeconomic groups, a phenomenon that is partially explained by the <u>social drift (downward drift) hypothesis</u>,</strong> which suggests that <strong>individuals with schizophrenia may move to lower socioeconomic status due to the impairments caused by the illness</strong>, which include difficulties in finding meaningful employment and become estranged from their families. Therefore, belonging to lower socioeconomic classes does not increase the likelihood of developing schizophrenia; rather, developing schizophrenia can lead to a downward drift in socioeconomic status.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Few important points on the epidemiology of schizophrenia-</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Downward drift hypothesis-&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">According to the <strong>downward drift hypothesis</strong>, people with <strong>schizophrenia are more likely to be found in lower socioeconomic classes</strong> (Statement D) because they may experience difficulties in finding meaningful employment and become estranged from their families, causing them to drift down the socioeconomic ladder.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Worldwide lifetime prevalence of Schizophrenia is approximately 0.7 per cent</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp; Both <strong>men and women are equally affected</strong>, but the onset of the illness tends to be earlier in males and later in females. The peak age of onset for schizophrenia is in adolescence and young adulthood, typically between 15 and 24 years. However, there is also a second peak in middle age for females. If the onset occurs after the age of 45, it is referred to as &quot;late-onset schizophrenia.<strong>&quot; It is more common in lower socioeconomic classes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 357.</span></strong></span></span></p>",
      "correct_choice_id": 35496,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8879,
      "choices": [
        {
          "id": 35483,
          "text": "<p>Auditory hallucinations of two or more voices conversing with each other</p>"
        },
        {
          "id": 35484,
          "text": "<p>Thought withdrawal</p>"
        },
        {
          "id": 35485,
          "text": "<p>Somatic hallucinations</p>"
        },
        {
          "id": 35486,
          "text": "<p>Thought broadcast</p>"
        }
      ],
      "text": "<p>Which of the following is NOT considered one of Schneider's first-rank symptoms in the context of schizophrenia?</p>",
      "unique_key": "Q1955196",
      "question_audio": null,
      "question_video": null,
      "map_id": 9124,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><strong>Ans. C) Somatic hallucinations</strong></p><p><strong>&nbsp;</strong></p><p><strong>Option C:</strong></p><p>&nbsp;</p><p>Somatic hallucinations which involve sensations or perceptions of something happening in the body that has no physical cause, are not listed among Schneider's first-rank symptoms of schizophrenia. While somatic hallucinations can occur in schizophrenia, they are not considered as specific or characteristic as the first-rank symptoms.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p>Schneider's first-rank symptoms of schizophrenia are a set of psychotic symptoms that were considered by psychiatrist Kurt Schneider to be particularly characteristic of schizophrenia.</p><p>&nbsp;</p><p><strong>These symptoms include:</strong></p><p>&nbsp;</p><p><strong>Option A</strong>.&nbsp; Auditory hallucinations of two or more voices conversing with each other or commenting on the person's actions.</p><p>&nbsp;</p><p><strong>Option B</strong>. Thought withdrawal where the individual believes that thoughts are being removed from their mind by an external force.</p><p>&nbsp;</p><p><strong>Option D</strong>. Thought broadcast where the individual believes that their thoughts are being broadcast or transmitted so that others can hear them.&nbsp;</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>\"Somatic Passivity\" (which is as a First Rank Symptom) and \"Somatic hallucinations\" (which is not a First Rank Symptom).&nbsp;</p><p>&nbsp;</p><p><strong>Somatic Passivity</strong>: The patient experiences bodily sensations but attributes them to an external agency or force controlling them (e.g., \"Someone is making me feel this pain\")&nbsp;</p><p>&nbsp;</p><p><strong>Somatic hallucinations</strong>: False perceptions of sensations in the body without attributing them to external control (e.g., feeling bugs crawling under the skin)</p><p>&nbsp;</p><p><strong>Ref</strong>: A Short Textbook of Psychiatry, 7th edition, Page No 55.</p>",
      "correct_choice_id": 35485,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8881,
      "choices": [
        {
          "id": 35491,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delusional mood</span></span></span></p>"
        },
        {
          "id": 35492,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sudden delusional idea</span></span></span></p>"
        },
        {
          "id": 35493,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delusional perception</span></span></span></p>"
        },
        {
          "id": 35494,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nihilistic delusion</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT a primary delusion?</span></span></p>",
      "unique_key": "Q1471166",
      "question_audio": null,
      "question_video": null,
      "map_id": 9126,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Nihilistic delusion</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nihilistic delusions&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are characterized by beliefs that one is dead, or that one&#39;s body parts or internal organs are missing or non-functioning, and the patient may deny the existence of their body, their mind, or the world in general. It is not one of the primary delusions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary delusions arise as a direct result of a morbid psychological process caused by the underlying disorder</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. They are intrinsic to psychotic conditions, particularly schizophrenia, and include:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Delusional mood:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In delusional mood, the <strong>patient experiences that there is something going on that concerns him</strong> but is not sure what it is.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Sudden delusional idea:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Here, a <strong>delusion appears fully formed in the mind of the patient</strong>. It is also called <strong>&quot;autochthonous delusion&quot;.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Delusional perception:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Here, a <strong>delusional meaning is attached to a normal perception</strong>, in an understandable manner.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary delusions&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are those that <strong>arise spontaneously and are not derived from previous experiences or external events</strong>. <strong>Delusional mood, delusional perception, and sudden delusional ideas are examples of primary delusions</strong>. <strong>Secondary delusions</strong> develop <strong>secondarily to some other psychopathology.</strong> For example, a patient who had auditory hallucinations and heard a voice that repeatedly said, &ldquo;you will be killed&rdquo;, started believing that &ldquo;somebody wants to kill him&quot;. This &ldquo;delusion of persecution&rdquo; that developed is a secondary delusion as it developed secondarily to the auditory hallucinations.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Fish&rsquo;s Clinical Psychopathology, 5th edition, Page 48-49.&nbsp;</span></strong></span></span></p>",
      "correct_choice_id": 35494,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8877,
      "choices": [
        {
          "id": 35475,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dementia praecox was characterized by a decline in cognitive function, while manic-depressive psychosis was characterized by fluctuations between depressive and manic episodes.</span></span></span></p>"
        },
        {
          "id": 35476,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dementia praecox referred to a cognitive decline in young individuals, while manic-depressive psychosis was exclusively seen in older adults.</span></span></span></p>"
        },
        {
          "id": 35477,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dementia praecox was an early term for bipolar disorder, while manic-depressive psychosis was an early term for schizophrenia.</span></span></span></p>"
        },
        {
          "id": 35478,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both dementia praecox and manic-depressive psychosis were characterized by psychosis, but dementia praecox was considered a more severe form.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements best describes Emil Kraepelin&rsquo;s classification of mental disorders?</span></span></p>",
      "unique_key": "Q5511790",
      "question_audio": null,
      "question_video": null,
      "map_id": 9122,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Dementia praecox was characterized by a decline in cognitive function, while manic-depressive psychosis was characterized by fluctuations between depressive and manic episodes.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emil Kraepelin&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is known for his <strong>contributions to the classification of mental disorders</strong> and is particularly noted for distinguishing between what he termed <strong>&quot;dementia praecox</strong>&quot; and <strong>&quot;manic-depressive psychosis</strong>.&quot; <strong>Dementia praecox</strong>, which later came to be known as schizophrenia, was characterized by&nbsp;&ndash;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delusions and hallucinations</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Long-term deteriorating course</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gradual cognitive decline</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (i.e., a gradual decline in cognitive functions such as memory, attention, and goal-directed behavior)</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On the other hand, <strong>manic-depressive psychosis</strong>, now known as <strong>bipolar disorder</strong>, was characterized by&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Distinct manic and depressive episodes</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Episodic illness alternating with periods of normal functioning</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unlike dementia praecox, which is a continuous and progressively deteriorating illness</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, there is no cognitive decline in manic depressive psychosis.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. This statement is <strong>incorrect</strong> because <strong>Kraepelin did not restrict dementia praecox to young individuals and manic-depressive psychosis to older adults</strong>. His classification was based on the type of symptoms and course of the illness rather than the age of onset.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. This statement <strong>reverses the modern terms for the disorders Kraepelin described</strong>. Dementia praecox is an early term for what is now known as schizophrenia, not bipolar disorder, and manic-depressive psychosis is an early term for what is now known as bipolar disorder, not schizophrenia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While both conditions involved psychosis, <strong>Kraepelin did not characterize dementia praecox simply as a more severe form of psychosis.</strong> He distinguished the two based on symptomatology, course, and outcome, with dementia praecox having a more chronic and deteriorating course.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/24/screenshot-2024-05-24-124930.JPG\" style=\"height:196px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Kaplan &amp; Sadock&rsquo;s Comprehensive Textbook of Psychiatry, 10th edition, Page 1406.</span></strong></span></span></p>",
      "correct_choice_id": 35475,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8908,
      "choices": [
        {
          "id": 35599,
          "text": "<p><span style=\"font-size:16px;\">Switch to olanzapine</span></p>"
        },
        {
          "id": 35600,
          "text": "<p><span style=\"font-size:16px;\">Switch to haloperidol</span></p>"
        },
        {
          "id": 35601,
          "text": "<p><span style=\"font-size:16px;\">Switch to amisulpride</span></p>"
        },
        {
          "id": 35602,
          "text": "<p><span style=\"font-size:16px;\">Switch to aripiprazole</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">A 28-year-old obese female patient with schizophrenia is currently being treated with risperidone. She has recently developed galactorrhea. What should be the next step in her treatment?</span></p>",
      "unique_key": "Q9843662",
      "question_audio": null,
      "question_video": null,
      "map_id": 9153,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. D) Switch to aripiprazole</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Risperidone is a second-generation antipsychotic</strong> known to cause <strong>hyperprolactinemia,&nbsp;</strong>which can <strong>result in galactorrhea, menstrual irregularities, and infertility in females</strong>, and <strong>gynecomastia, sexual dysfunction, and infertility in males</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Aripiprazole</strong>, on the other hand, has a <strong>lower risk of causing hyperprolactinemia due to its unique mechanism of action as a partial agonist at dopamine D2 receptors</strong>. Switching to aripiprazole may help alleviate the patient's galactorrhea while still providing effective treatment for schizophrenia.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A. Switch to olanzapine:&nbsp;</strong>While olanzapine is a <strong>second-generation antipsychotic with a lower risk of hyperprolactinemia compared to risperidone</strong>, it is associated with a <strong>higher risk of weight gain and metabolic side effects</strong>. Given the patient's obesity, olanzapine may not be the best choice.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B. Switch to haloperidol:&nbsp;</strong>Haloperidol is a <strong>first-generation antipsychotic that can also cause hyperprolactinemia</strong>, and it has a <strong>higher risk of extrapyramidal side effects compared to second-generation antipsychotics</strong>. Switching to haloperidol may not alleviate the patient's galactorrhea and could introduce additional side effects.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C. Switch to amisulpride:&nbsp;</strong>Amisulpride is another <strong>second-generation antipsychotic that can cause hyperprolactinemia.</strong> Switching to amisulpride may not effectively address the patient's galactorrhea and could potentially exacerbate the issue.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Hyperprolactinemia can occur secondary to antipsychotic use due to blockage of D2 receptors in the <strong>tuberoinfundibular tract</strong>. Clinical features include galactorrhea, menstrual disturbances in females and gynecomastia, impotence in males. <strong>Drug of choice</strong> is <strong>aripiprazole</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Ref</u>: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 168-169.</strong></span></p>",
      "correct_choice_id": 35602,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38186,
      "choices": [
        {
          "id": 152507,
          "text": "<p>1, 3 and 4 are correct</p>"
        },
        {
          "id": 152508,
          "text": "<p>Only 2 is correct</p>"
        },
        {
          "id": 152509,
          "text": "<p>1 and 2 are correct</p>"
        },
        {
          "id": 152510,
          "text": "<p>All are correct</p>"
        }
      ],
      "text": "<p>A 56-year-old male with a history of schizophrenia is started on chlorpromazine, a typical antipsychotic medication. The patient subsequently reports experiencing sedation, dry mouth, episodes of hypotension, tremors and rigidity. These side effects are related to the drug's interaction with specific receptors. Which combination of receptors is implicated in the side effects experienced by this patient?&nbsp;</p><ol><li>D2 and 5HT2 receptors&nbsp;</li><li>GABA and alpha-adrenergic receptors&nbsp;</li><li>Muscarinic M1 and alpha-adrenergic receptors&nbsp;</li><li>H1 receptors</li></ol>",
      "unique_key": "Q5918488",
      "question_audio": null,
      "question_video": null,
      "map_id": 23882,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><strong>Ans. A) 1, 3 and 4 are correct</strong></p><p><strong>&nbsp;</strong></p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p>Chlorpromazine is a typical antipsychotic that works primarily through dopamine D2 receptor antagonism, which helps in alleviating psychotic symptoms. However, it also has a high affinity for other receptors, leading to various side effects.</p><p>&nbsp;</p><p><strong>D2 and 5HT2 receptors</strong>: Chlorpromazineâ€™s antagonistic action on D2 receptors helps in controlling psychosis, but it can also lead to extrapyramidal symptoms. Its action on 5HT2 receptors contributes to its antipsychotic effects and side effect profile.</p><p>&nbsp;</p><p><strong>GABA and alpha-adrenergic receptors</strong>: While chlorpromazine may have some effect on these receptors, they are not primarily responsible for the sedation, dry mouth, and hypotension observed in patients.</p><p>&nbsp;</p><p><strong>Muscarinic M1 and alpha-adrenergic receptors</strong>: Chlorpromazineâ€™s antagonism of muscarinic M1 receptors can lead to anticholinergic effects such as dry mouth. Its action on alpha-adrenergic receptors can cause orthostatic hypotension.</p><p>&nbsp;</p><p><strong>H1 receptors</strong>: Antagonism of H1 receptors by chlorpromazine can lead to sedative effects.</p><p>&nbsp;</p><p>Therefore, receptors 1, 3, and 4 (D2 and 5HT2 receptors, muscarinic M1 and alpha-adrenergic receptors, and H1 receptors) are involved in the side effects experienced by the patient, making option A the correct answer.</p><p>&nbsp;</p><p><strong>Educational Objective:&nbsp;</strong></p><p>&nbsp;</p><p>Chlorpromazine (a low-potency typical antipsychotic) has the following receptor interactions related to the side effects mentioned:</p><ol><li>D2 receptor antagonism: Causes extrapyramidal symptoms (tremors, rigidity)</li><li>Muscarinic (M1) receptor antagonism: Causes anticholinergic effects (dry mouth)</li><li>Alpha-adrenergic receptor antagonism: Causes orthostatic hypotension</li><li>H1 receptor antagonism: Causes sedation</li></ol><p>&nbsp;</p><p>Chlorpromazine has minimal effect on GABA receptors</p><p>&nbsp;</p><p><strong>Ref</strong>: Stahlâ€™s Essential Psychopharmacology, Neuroscientific basis and practical applications, 5th edition, Page No 201-202.</p>",
      "correct_choice_id": 152507,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8887,
      "choices": [
        {
          "id": 35515,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delusions</span></span></span></p>"
        },
        {
          "id": 35516,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hallucinations</span></span></span></p>"
        },
        {
          "id": 35517,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Negative symptoms</span></span></span></p>"
        },
        {
          "id": 35518,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Catatonic symptoms</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year-old male presents to the outpatient psychiatric clinic with his mother. She reports that over the past six months, her son has become increasingly withdrawn, spending most of his time alone in his room. He often talks to himself, claiming that he is speaking with a character from a TV show who instructs him to perform certain tasks. He has also developed odd beliefs, insisting that he has a special ability to control the weather. His sleep pattern has become irregular, and his personal hygiene has significantly deteriorated. Based on these findings, which of the following symptoms of schizophrenia is NOT present in this patient?</span></span></p>",
      "unique_key": "Q3888249",
      "question_audio": null,
      "question_video": null,
      "map_id": 9132,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Catatonic symptoms</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Catatonic symptoms</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (correct answer) -</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>No catatonic symptoms have been mentioned in the patient&#39;s presentation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>clinical vignette does not include any evidence of catatonic behavior</strong>.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Delusions -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>patient&#39;s belief in his special ability to control the weather is an example of a delusion</strong>, specifically a delusion of grandeur.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hallucinations - </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s experience of<strong> hearing a character from a TV show speaking to him </strong>is suggestive of an<strong> auditory hallucination.</strong>&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Negative symptoms -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>patient&#39;s social withdrawal</strong> (asociality), poor hygiene (avolition), are suggestive of <strong>negative symptoms</strong>.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>schizophrenia</strong>, <strong>positive symptoms</strong> include <strong>delusions and hallucinations,</strong> <strong>negative symptoms</strong> include <strong>social withdrawal and neglect of personal hygiene</strong>, and <strong>catatonic symptoms</strong> involve a <strong>marked decrease in reactivity to the environment</strong>. Based on the case description, this patient exhibits delusions, hallucinations, and negative symptoms, but there is no evidence of catatonic symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 340.</span></strong></span></span></p>",
      "correct_choice_id": 35518,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8889,
      "choices": [
        {
          "id": 35523,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Waxy flexibility</span></span></span></p>"
        },
        {
          "id": 35524,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stereotypy</span></span></span></p>"
        },
        {
          "id": 35525,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mutism</span></span></span></p>"
        },
        {
          "id": 35526,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stupor</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old female with a history of schizophrenia is brought to the emergency department by her family due to worsening symptoms. On examination, she was found to be completely immobile and unresponsive to external stimuli. Which of the following catatonic symptoms of schizophrenia is most likely present in this patient?</span></span></p>",
      "unique_key": "Q1768000",
      "question_audio": null,
      "question_video": null,
      "map_id": 9134,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Stupor</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The symptoms of patient are suggestive of <strong>stupor</strong>.&nbsp; <strong>Stupor is a state of extreme inactivity or immobility</strong> (akinesis) and the <strong>patient is minimally responsive to any kind of stimulus</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Waxy flexibility:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It refers to the <strong>feeling of plastic resistance</strong>, which the <strong>examiner experiences while making a passive movement on the patient</strong>. This feeling is akin to bending a wax candle, hence the name &#39;waxy flexibility.&#39;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Stereotypy:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stereotypy is the <strong>spontaneous repetition of odd, purposeless movements</strong>.&nbsp; E.g., A patient would repeatedly and spontaneously do hand-flapping movements.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Mutism:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Absence of <strong>verbal communication or minimal verbal response</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features of catatonia include</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-142949.jpg\" style=\"height:835px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Kaplan &amp; Sadock&rsquo;s Comprehensive Textbook of Psychiatry, 10th edition, Page No 1595.</span></strong></span></span></p>",
      "correct_choice_id": 35526,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8891,
      "choices": [
        {
          "id": 35531,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizophreniform disorder</span></span></span></p>"
        },
        {
          "id": 35532,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizoaffective disorder</span></span></span></p>"
        },
        {
          "id": 35533,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizophrenia</span></span></span></p>"
        },
        {
          "id": 35534,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delusional disorder</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old male with no previous psychiatric history presents to the emergency department with a 6-month history of hearing voices and suspiciousness. He believes that he is being followed by the government and that they are trying to control his mind. He has also become increasingly isolated and withdrawn from his family and friends. On examination, he is found to have disorganized speech, flattened affect, and decreased motivation. Laboratory tests and brain imaging are unremarkable. What is the most likely diagnosis for this patient?</span></span></p>",
      "unique_key": "Q8859438",
      "question_audio": null,
      "question_video": null,
      "map_id": 9136,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Schizophrenia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient <strong>presents with a 6-month history of hearing voices</strong> (suggestive of auditory hallucinations) and <strong>delusions of persecution and probably, delusion of control</strong> (suspiciousness of being followed by the government, and belief that someone is controlling the mind) <strong>as well as disorganized speech, flattened affect, and decreased motivation</strong> (negative symptoms). These symptoms are consistent with the diagnosis of <strong>schizophrenia</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizophrenia is characterized by positive symptoms (such as hallucinations and delusions), negative symptoms (such as social withdrawal, apathy, and impaired self-care), and cognitive symptoms (such as disorganized thoughts).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Schizophreniform disorder&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>diagnosis given to patients who present with symptoms of schizophrenia but duration of illness</strong> is between one month to six months.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Schizoaffective disorder&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a diagnosis <strong>given to patients who have symptoms of both schizophrenia and a mood disorder</strong>, such as <strong>depression or bipolar disorder</strong>. Delusional disorder is a diagnosis given to patients who have persistent delusions without the presence of other schizophrenia symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Delusional disorder&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a diagnosis given to <strong>patients who have persistent delusions without the presence of other schizophrenia symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizophrenia is the prototype of psychotic disorder. According to DSM-5, <strong>two or more</strong> of the following symptoms should be present for the duration of <strong>1 month</strong> and <strong>at least one of these must be (1), (2), or (3)</strong>.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delusions</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hallucinations</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disorganized speed (or formal thought disorder)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disorganized behavior</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Negative symptoms</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total duration of illness should be <strong>at least 6 months</strong> and the 6 months period must include at least one month of above-mentioned symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The symptoms must also cause <strong>significant impairment in social, occupational, or other areas of functioning, and cannot be attributed to the effects</strong> of a substance or another medical condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 341.</span></strong></span></span></p>",
      "correct_choice_id": 35533,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8897,
      "choices": [
        {
          "id": 35555,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lorazepam</span></span></span></p>"
        },
        {
          "id": 35556,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benztropine</span></span></span></p>"
        },
        {
          "id": 35557,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol</span></span></span></p>"
        },
        {
          "id": 35558,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluoxetine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old male patient presents to the psychiatric clinic with a history of social withdrawal, delusions, and auditory hallucinations. The patient has been diagnosed with schizophrenia and is being started on haloperidol for management. To prevent the development of extrapyramidal symptoms (EPS), which drug should be given prophylactically?</span></span></span></p>",
      "unique_key": "Q1217236",
      "question_audio": null,
      "question_video": null,
      "map_id": 9142,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Benztropine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Haloperidol is a first-generation antipsychotic medication</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> that <strong>acts as a potent dopamine D2 receptor antagonist</strong>. Due to its <strong>strong affinity for dopamine receptors</strong>, <strong>haloperidol is associated with a higher risk of developing extrapyramidal symptoms</strong> (EPS) such as drug-induced parkinsonism, akathisia, dystonia, and tardive dyskinesia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benztropine&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(choice B) is an <strong>anticholinergic medication</strong> that can be <strong>used prophylactically to prevent the development of EPS in patients starting on haloperidol.</strong> It works by blocking central cholinergic receptors, thereby restoring the balance between dopamine and acetylcholine in the nigrostriatal pathway. This helps reduce the risk of EPS.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Lorazepam&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>benzodiazepine and not typically used for preventing EPS</strong> in patients on antipsychotic medications.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Propranolol&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>beta-blocker that may help manage akathisia</strong>, a specific type of EPS, but it is not typically used as a prophylactic measure to prevent EPS.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Fluoxetine&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>selective serotonin reuptake inhibitor</strong> (SSRI), it does not have a role in preventing EPS in patients on antipsychotic medications.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To <strong>prevent the development of extrapyramidal symptoms associated with first-generation antipsychotic medications</strong> like <strong>haloperidol, anticholinergic agents such as benztropine are commonly used</strong>. Benztropine can help counteract the dopaminergic blockade in the nigrostriatal pathway, which is thought to contribute to the development of EPS.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 351.</span></span></strong></p>",
      "correct_choice_id": 35556,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8898,
      "choices": [
        {
          "id": 35559,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serotonin Syndrome</span></span></span></p>"
        },
        {
          "id": 35560,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute akathisa</span></span></span></p>"
        },
        {
          "id": 35561,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute Dystonia</span></span></span></p>"
        },
        {
          "id": 35562,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neuroleptic Malignant Syndrome</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old male with a history of schizophrenia was recently started on haloperidol for treatment of his psychotic symptoms. Three days after starting the medication, he presents to the emergency room with a high fever of 104&deg;F, diaphoresis, tachycardia, muscle rigidity, and altered mental status. His laboratory results show elevated creatine kinase and leukocytosis. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q5466064",
      "question_audio": null,
      "question_video": null,
      "map_id": 9143,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Neuroleptic Malignant Syndrome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation of high fever, muscle rigidity, altered mental status, and autonomic instability (evidenced by diaphoresis and tachycardia), along with laboratory findings of elevated creatine kinase and leukocytosis shortly after starting haloperidol, is indicative of <strong>Neuroleptic Malignant Syndrome (NMS)</strong>. <strong>NMS is a rare but life-threatening reaction associated with the use of neuroleptic</strong> (antipsychotic) drugs, particularly <strong>first-generation antipsychotics like haloperidol</strong>. The key features of NMS include severe muscle rigidity, fever, autonomic instability, and altered mental status.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Serotonin syndrome&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">typically occurs <strong>due to the use of serotonergic medications</strong>, such as <strong>selective serotonin reuptake inhibitors</strong> (SSRIs).&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Acute Akathisia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an <strong>extrapyramidal side effect of antipsychotic medications</strong>, characterized by a <strong>subjective feeling of inner restlessness and objective signs of restlessness</strong>. While it can occur after starting an antipsychotic, the fever, muscle rigidity, and autonomic instability seen in this case are not characteristic of acute akathisia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Acute Dystonia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an <strong>extrapyramidal side effect of antipsychotic medications,</strong> characterized by <strong>sudden, involuntary muscle contractions</strong> and can <strong>present as torticollis, oculogyric crisis, or other focal dystonias</strong>. While it can occur after starting an antipsychotic, the fever and autonomic instability seen in this case are not characteristic of acute dystonia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NMS is a fatal side effect of antipsychotic use</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. It is characterized by the following cardinal symptoms:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fever, typically greater than 100.4&deg;F (38&deg;C)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle rigidity</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Altered mental status: Confusion, agitation, or stupor</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Autonomic instability: Tachycardia, diaphoresis, labile blood pressure, and tachypnea</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laboratory findings include elevated creatine kinase, leukocytosis, elevated liver enzymes and sometimes acute renal failure due to rhabdomyolysis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PATHOPHYSIOLOGY OF NMS</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/picture2_DpCtKQs.jpg\" style=\"height:751px; width:700px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 594-595.</span></strong></span></span></p>",
      "correct_choice_id": 35562,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8900,
      "choices": [
        {
          "id": 35567,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bromocriptine</span></span></span></p>"
        },
        {
          "id": 35568,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benztropine</span></span></span></p>"
        },
        {
          "id": 35569,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dantrolene</span></span></span></p>"
        },
        {
          "id": 35570,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lorazepam</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old female with a history of bipolar disorder was recently started on olanzapine for the management of her manic symptoms. Five days after starting the medication, she presents to the emergency room with high-grade fever, diaphoresis, tachycardia, muscle rigidity, and confusion. Her laboratory results show elevated creatine kinase and leukocytosis. The clinical presentation is consistent with<strong> </strong></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neuroleptic Malignant Syndrome (NMS). What is the drug of choice for the treatment of NMS?</span></span></p>",
      "unique_key": "Q8051219",
      "question_audio": null,
      "question_video": null,
      "map_id": 9145,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Dantrolene</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dantrolene&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the <strong>drug of choice for the treatment of Neuroleptic Malignant Syndrome</strong> (NMS). It is a <strong>direct-acting skeletal muscle relaxant</strong> that works by <strong>inhibiting calcium release from the sarcoplasmic reticulum</strong>, thereby <strong>reducing muscle rigidity and hyperthermia</strong>. In addition to dantrolene, supportive care, hydration, and discontinuation of the offending antipsychotic medication are essential components of NMS management.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Bromocriptine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In some cases, <strong>dopamine agonists like bromocriptine may also be used to alleviate symptoms</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B Benztropine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an <strong>anticholinergic agent used primarily to treat extrapyramidal side effects</strong> (EPS).&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Lorazepam:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It can be used as an <strong>adjunct treatment for NMS to help manage agitation and provide sedation</strong>, but it is not the primary treatment for NMS, as it does not address the core features of the syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kindy note neuroleptic malignant syndrome is rare with second-generation antipsychotics like olanzapine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment includes discontinuing the antipsychotic medication, providing supportive care, and considering the use of a medication</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> like <strong>dantrolene</strong>, dopamine agonists such as amantadine and bromocriptine to address the dopamine dysregulation associated with NMS.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 594-595.</span></strong></span></span></p>",
      "correct_choice_id": 35569,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8909,
      "choices": [
        {
          "id": 35603,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Late age of onset</span></span></span></p>"
        },
        {
          "id": 35604,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute onset</span></span></span></p>"
        },
        {
          "id": 35605,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presence of mood symptoms</span></span></span></p>"
        },
        {
          "id": 35606,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Predominance of negative symptoms</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following factors are associated with a good prognosis in schizophrenia, except:</span></span></p>",
      "unique_key": "Q8670997",
      "question_audio": null,
      "question_video": null,
      "map_id": 9154,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Predominance of negative symptoms</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>predominance of negative symptoms such as avolition, anhedonia, social withdrawal and diminished emotional expression</strong> is associated with a <strong>poorer prognosis in schizophrenia,</strong> as these symptoms are generally more difficult to treat and may persist even when other symptoms, such as hallucinations and delusions, are under control.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Late age of onset:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Typically, a <strong>later age of onset is associated with a better prognosis in schizophrenia.</strong> Early-onset schizophrenia tends to have a more severe course and poorer outcome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Acute onset:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An acute onset of schizophrenia symptoms, <strong>often triggered by a stressful event, tends to be associated with a better prognosis</strong> compared to a gradual, insidious onset.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Presence of mood symptoms:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of mood symptoms (depressive or manic symptoms) <strong>in the context of schizophrenia can sometimes be associated with a better prognosis</strong>, partly because mood symptoms may respond better to treatment compared to core schizophrenic symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>prognosis in schizophrenia is generally worse with a predominance of negative symptoms</strong>. Factors associated with a better prognosis include a later age of onset, acute onset of symptoms, and the presence of mood symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-143233.jpg\" style=\"height:264px; width:700px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 350.</span></strong></span></span></p>",
      "correct_choice_id": 35606,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8918,
      "choices": [
        {
          "id": 35639,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizotypal Personality Disorder</span></span></span></p>"
        },
        {
          "id": 35640,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Borderline Personality Disorder</span></span></span></p>"
        },
        {
          "id": 35641,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Narcissistic Personality Disorder</span></span></span></p>"
        },
        {
          "id": 35642,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antisocial Personality Disorder</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among various psychiatric conditions, one specific disorder has a notable difference in classification between the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) and the International Classification of Diseases, 11th Revision (ICD-11). Which of the following disorders is considered a personality disorder in the DSM-5 and a part of the schizophrenia or other primary psychotic disorders group in the ICD-11?</span></span></p>",
      "unique_key": "Q6754427",
      "question_audio": null,
      "question_video": null,
      "map_id": 9159,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Schizotypal Personality Disorder</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizotypal Personality Disorder (STPD</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">) is characterized by<strong> odd and eccentric beliefs and behaviours</strong>, and <strong>difficulties with forming and maintaining social relationships</strong>. The <strong>Diagnostic and Statistical Manual of Mental Disorders, 5th Edition</strong> (DSM-5) classifies <strong>STPD as a personality disorder within the Cluster A personality disorders</strong>, which are characterized by <strong>odd or eccentric behaviors</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In contrast, the <strong>International Classification of Diseases, 11th Revision</strong> (ICD-11) <strong>classifies STPD under the category of &quot;schizophrenia or other primary psychotic disorders</strong>.&quot; This difference in classification stems from the similarities between STPD and schizophrenia, as both disorders share some symptoms, such as magical thinking, unusual perceptual experiences, and social withdrawal. The DSM-5 emphasizes the enduring personality traits of STPD, whereas the ICD-11 focuses on its relationship with the broader group of primary psychotic disorders.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Borderline Personality Disorder</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, <strong>Option C. Narcissistic Personality Disorder</strong>, and <strong>Option D. Antisocial Personality Disorde</strong>r are consistently classified as <strong>personality disorders across both the DSM-5 and the ICD-11</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizotypal Personality Disorder&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is categorized as a <strong>personality disorder in the DSM-5</strong> but is <strong>considered part of the schizophrenia or other primary psychotic disorders group in the ICD-11</strong>, highlighting a notable difference in classification between these two diagnostic systems.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><u>Ref</u>: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 563.</strong></span></span></span></p>",
      "correct_choice_id": 35639,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8888,
      "choices": [
        {
          "id": 35519,
          "text": "<p>Avolition</p>"
        },
        {
          "id": 35520,
          "text": "<p>Alogia</p>"
        },
        {
          "id": 35521,
          "text": "<p>Anhedonia</p>"
        },
        {
          "id": 35522,
          "text": "<p>Affective flattening</p>"
        }
      ],
      "text": "<p>A 26-year-old female patient with schizophrenia came for a follow-up visit along with her concerned sister. The sister reports that over the past year, there is no hallucinatory behaviour or suspiciousness however, the patient has no interest in social activities, is less verbally expressive, and spends most of her time alone in her room. She has also noticed that her sister has had difficulty maintaining employment due to a lack of motivation and poor self-care. Based on these findings, which of the following negative symptoms of schizophrenia is NOT present in this patient?</p>",
      "unique_key": "Q7352411",
      "question_audio": null,
      "question_video": null,
      "map_id": 9133,
      "difficulty_level": "difficult",
      "subjects_id": [
        16
      ],
      "solution": "<p><strong>Ans. D) Affective flattening</strong></p><p><strong>&nbsp;</strong></p><p><strong>Option D:</strong></p><p>&nbsp;</p><p><strong>Based on the sister's observations, the patient exhibits several negative symptoms of schizophrenia</strong>:</p><p>&nbsp;</p><p>Affective flattening involves a reduction in the expression of emotions through facial expressions, voice tone, eye contact, and body language. While the sister reports that the patient is less expressive in terms of being less talkative and less interested in activities, there is no specific mention of the patient's emotional expression being diminished. The lack of detailed information on the patient's emotional expressiveness, such as reduced facial expressions or a monotone voice, makes it difficult to conclusively identify affective flattening based on the provided description.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Avolition</strong>: This refers to a lack of motivation to initiate and carry out goal-directed activities. The difficulty maintaining employment due to a lack of motivation is indicative of avolition.</p><p>&nbsp;</p><p><strong>Option B. Alogia</strong>: This is characterized by a reduction in the amount of speech and the content of speech. The sister's report that the patient is less expressive aligns with the symptom of alogia.</p><p>&nbsp;</p><p><strong>Option C. Anhedonia</strong>: This is the inability to experience pleasure from activities usually found enjoyable. The patient's lack of interest in social activities can be considered a sign of anhedonia.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Negative symptoms represent â€œloss of normal functionsâ€ of the brain in patients with schizophrenia. Negative symptoms do not respond as well to the antipsychotics as positive symptoms.&nbsp;</p><p>&nbsp;</p><p><strong>Avolition</strong>: Avolition refers to the diminished motivation or drive to engage in goal-directed activities, such as personal grooming, educational pursuits, or work-related tasks.</p><p>&nbsp;</p><p><strong>Apathy</strong>: Apathy is characterized by a lack of concern for the outcome of an action or event, like a student with schizophrenia who fails an exam but appears completely unfazed by the result.</p><p>&nbsp;</p><p><strong>Anhedonia</strong>: Anhedonia is the inability to derive pleasure from activities or relationships that were once enjoyable, such as a cricket fan who ceases to play or watch the sport because he no longer finds it pleasurable.</p><p>&nbsp;</p><p><strong>Asociality</strong>: Asociality is a marked disinterest in socializing and a general indifference to social connections, even with close family and friends.</p><p>&nbsp;</p><p><strong>Affective flattening (or blunting)</strong>: Affective flattening describes the limited or severely restricted expression of emotions.</p><p>&nbsp;</p><p><strong>Alogia</strong>: Alogia is characterized by reduced speech output.</p><p>&nbsp;</p><p><strong>Ref</strong>: Kaplan &amp; Sadockâ€™s Synopsis of Psychiatry, 12th edition, Page No 340.</p>",
      "correct_choice_id": 35522,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8886,
      "choices": [
        {
          "id": 35511,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased dopamine levels in the prefrontal cortex lead to positive symptoms of schizophrenia</span></span></span></p>"
        },
        {
          "id": 35512,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased dopamine levels in the prefrontal cortex lead to positive symptoms of schizophrenia</span></span></span></p>"
        },
        {
          "id": 35513,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased dopamine levels in the mesolimbic pathway lead to negative symptoms of schizophrenia</span></span></span></p>"
        },
        {
          "id": 35514,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased dopamine levels in the mesolimbic pathway lead to positive symptoms of schizophrenia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The dopamine hypothesis of schizophrenia postulates that:</span></span></p>",
      "unique_key": "Q9131655",
      "question_audio": null,
      "question_video": null,
      "map_id": 9131,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Increased dopamine levels in the mesolimbic pathway lead to positive symptoms of schizophrenia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>dopamine hypothesis of schizophrenia</strong> is one of the <strong>most studied theories regarding the pathophysiology of schizophrenia</strong>. It <strong>postulates that an overactivity of dopamine transmission in certain brain pathways, particularly the mesolimbic pathway</strong>, is associated with the <strong>positive symptoms of schizophrenia</strong>, such as hallucinations, delusions, and thought disorders. The mesolimbic pathway, which runs from the ventral tegmental area (VTA) to the limbic system, including the nucleus accumbens, is a key component of the brain&#39;s reward system and is implicated in the generation of these symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A. Increased dopamine levels in the prefrontal cortex are not directly associated with the positive symptoms of schizophrenia</strong>. In fact, the dopamine hypothesis suggests that <strong>negative symptoms and cognitive deficits in schizophrenia</strong> might be related to <strong>decreased dopamine activity in the prefrontal cortex</strong> (hypofrontality).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B. Decreased dopamine levels in the prefrontal cortex are thought to contribute to the negative symptoms of schizophrenia</strong> (such as apathy, anhedonia, and impaired executive function), <strong>not the positive symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C. Increased dopamine levels in the mesolimbic pathway are associated with positive symptoms of schizophrenia, </strong>not <strong>negative symptoms</strong>. Negative symptoms are more closely related to decreased dopamine activity in the prefrontal cortex.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>dopamine hypothesis of schizophrenia</strong> suggests that an <strong>imbalance of dopaminergic activity in the brain contributes to the development of schizophrenia.</strong> The hypothesis posits that</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased dopaminergic activity in the mesolimbic pathway</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (which connects the ventral tegmental area to the nucleus accumbens) is responsible for the positive symptoms of schizophrenia.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased dopaminergic activity in the mesocortical tract</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (which connects the ventral tegmental area to the prefrontal cortex) is responsible for the negative symptoms.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In addition, some studies have found increased levels of serotonin, increased levels of glutamate and decreased GABA in patients with schizophrenia.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 361.</span></strong></span></span></p>",
      "correct_choice_id": 35514,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8893,
      "choices": [
        {
          "id": 35539,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clozapine</span></span></span></p>"
        },
        {
          "id": 35540,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Haloperidol</span></span></span></p>"
        },
        {
          "id": 35541,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Olanzapine</span></span></span></p>"
        },
        {
          "id": 35542,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aripiprazole</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 29-year-old obese male patient with a history of auditory hallucinations, delusions, and social withdrawal for the past year presents to the clinic. He has no prior history of substance abuse or head trauma. He has been previously treated with first-generation antipsychotic medication, but experienced significant extrapyramidal symptoms, including acute dystonia and troublesome tremors, because of which he stopped the treatment. Which of the following treatment options would be most appropriate for this patient?</span></span></p>",
      "unique_key": "Q4640001",
      "question_audio": null,
      "question_video": null,
      "map_id": 9138,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Aripiprazole</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient presents with symptoms consistent with <strong><u>schizophrenia</u></strong>, and he has <strong>experienced extrapyramidal side effects from a first-generation antipsychotic</strong> which was a <strong>cause of poor compliance</strong>. In this situation, it is necessary to <strong>switch to a second-generation</strong> (atypical) <strong>antipsychotic, as they have a lower risk of extrapyramidal side effects</strong>. <strong>Aripiprazole</strong> is a <strong>second-generation antipsychotic</strong> that has a <strong>lower risk of extrapyramidal side effects</strong> compared to first-generation antipsychotics. Additionally, aripiprazole is associated with a lower risk of metabolic side effects compared to olanzapine, making it a more suitable choice for this patient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Clozapine&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>second-generation antipsychotic</strong> that is the drug of choice in treatment-resistant schizophrenia. However, it is not the first choice due to its risk of serious adverse effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Haloperidol&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>first-generation antipsychotic</strong> that is not appropriate for this patient, as he has already experienced extrapyramidal side effects from a similar medication.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Olanzapine&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>second-generation antipsychotic</strong> that could potentially be used in this case. However, it has a <strong>higher risk of metabolic side effects</strong> (e.g., weight gain, hyperglycemia) compared to other atypical antipsychotics. Since the patient is already obese, olanzapine should be avoided.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with <strong>schizophrenia</strong> who have experienced significant <strong>extrapyramidal side effects from first-generation antipsychotics</strong> and have concerns about <strong>weight gain, aripiprazole is a suitable treatment option due to its lower risk of EPS and relatively favorable metabolic profile</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 123.</span></strong></span></span></p>",
      "correct_choice_id": 35542,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8895,
      "choices": [
        {
          "id": 35547,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Haloperidol</span></span></span></p>"
        },
        {
          "id": 35548,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol</span></span></span></p>"
        },
        {
          "id": 35549,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sertraline</span></span></span></p>"
        },
        {
          "id": 35550,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tetrabenazine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old male with a history of schizophrenia was recently started on an antipsychotic medication 2 weeks ago. He is brought to the clinic by his family due to feeling restless, constantly needing to move, and being unable to sit still. He has no other significant medical history. What is the most appropriate treatment for this patient&#39;s symptoms?</span></span></p>",
      "unique_key": "Q8997853",
      "question_audio": null,
      "question_video": null,
      "map_id": 9140,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Propranolol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s symptoms of <strong>restlessness, a constant need to move</strong>, and an <strong>inability to sit still is suggestive of akathisia</strong>. <strong>Akathisia</strong> is a common <strong>extrapyramidal side effect of antipsychotic medications</strong>, particularly <strong>first-generation</strong> (typical) <strong>antipsychotics</strong>. <strong>Propranolol</strong> is a <strong>non-selective beta-blocker</strong> and is considered as the first line treatment for the management of akathisia.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Haloperidol&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>first-generation antipsychotic,</strong> which may <strong>exacerbate akathisia</strong> and is not an appropriate treatment in this case.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sertraline&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>selective serotonin reuptake inhibitor</strong> (SSRI) and is <strong>not effective in treating akathisia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Tetrabenazine&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>vesicular monoamine transporter 2</strong> (VMAT2) <strong>inhibitor</strong>, used in the treatment of tardive dyskinesia, not akathisia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute akathisia is the <strong>commonest side effect</strong> of antipsychotic medications. It is characterized by an <strong>inner sense of restlessness</strong> along with <strong>objective</strong>, <strong>observable movements</strong> such as <strong>fidgeting</strong> of legs, <strong>pacing around</strong>, <strong>inability to sit</strong> or <strong>stand</strong> in one place for a long time. <strong>Drug of choice </strong>is <strong>&beta;-blockers</strong> such as propranolol. Other treatment options include <strong>anticholinergics </strong>and <strong>benzodiazepines</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.&nbsp;</span></strong></span></span></p>",
      "correct_choice_id": 35548,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8901,
      "choices": [
        {
          "id": 35571,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aripiprazole has a higher affinity for serotonin 5-HT2A receptors compared to dopamine D2 receptors</span></span></span></p>"
        },
        {
          "id": 35572,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aripiprazole acts primarily as a dopamine D2 receptor antagonist</span></span></span></p>"
        },
        {
          "id": 35573,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aripiprazole functions as a partial agonist at dopamine D2 receptors and serotonin 5-HT1A receptors</span></span></span></p>"
        },
        {
          "id": 35574,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aripiprazole selectively inhibits serotonin reuptake</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old female with a history of major depressive disorder with psychotic features is prescribed aripiprazole as an adjunct treatment. How does the mechanism of action of aripiprazole differ from other second-generation antipsychotics?</span></span></p>",
      "unique_key": "Q6991181",
      "question_audio": null,
      "question_video": null,
      "map_id": 9146,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Aripiprazole functions as a partial agonist at dopamine D2 receptors and serotonin 5-HT1A receptors</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aripiprazole is unique among second-generation</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (atypical) <strong>antipsychotics due to its mechanism of action</strong> as a <strong>partial agonist at dopamine D2 receptors and serotonin 5-HT1A receptors</strong>, while also acting as an <strong><u>antagonist at serotonin 5-HT2A receptors</u></strong>. This partial agonist activity allows aripiprazole to stabilize dopamine and serotonin activity in brain regions where these neurotransmitters may be imbalanced, contributing to its antipsychotic and antidepressant effects. This mechanism differs from many other atypical antipsychotics, which primarily act as antagonists at dopamine and serotonin receptors.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><span style=\"font-family:Calibri,sans-serif\"><strong>A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>While aripiprazole does interact with serotonin 5-HT2A receptors</strong>, its unique characteristic is <strong>not a higher affinity for these receptors over dopamine D2 receptors</strong> but its partial agonist activity at dopamine D2 and serotonin 5-HT1A receptors.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><span style=\"font-family:Calibri,sans-serif\"><strong>B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aripiprazole is not primarily a dopamine D2 receptor antagonist</strong>; it is a <strong>partial agonist at these receptors</strong>, which means it can act as both an agonist and an antagonist depending on the level of neurotransmitter activity.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><span style=\"font-family:Calibri,sans-serif\"><strong>D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aripiprazole does not selectively inhibit serotonin reuptake</strong>; this is a <strong>mechanism associated with selective serotonin reuptake inhibitors</strong> (SSRIs), a class of antidepressants.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aripiprazole&#39;s mechanism of action differs from other second-generation antipsychotics</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> in that it <strong>functions as a partial agonist at dopamine D2 receptors and serotonin 5-HT1A receptors</strong>, and as an <strong>antagonist at serotonin 5-HT2A receptors.</strong> This allows it to modulate dopamine and serotonin activity in a way that can help stabilize these neurotransmitter systems in conditions like schizophrenia and major depressive disorder with psychotic features. Because of this unique mechanism of action, aripiprazole is associated with a lower risk of extrapyramidal side effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Ref</u>: Stahl&rsquo;s Essential Psychopharmacology, Neuroscientific Basis and Practical Applications, Page 239.</span></strong></span></span></p>",
      "correct_choice_id": 35573,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8903,
      "choices": [
        {
          "id": 35579,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add a mood stabilizer to the treatment regimen</span></span></span></p>"
        },
        {
          "id": 35580,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Switch to a first-generation antipsychotic</span></span></span></p>"
        },
        {
          "id": 35581,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Switch to clozapine</span></span></span></p>"
        },
        {
          "id": 35582,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Consider electroconvulsive therapy</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 26-year-old male presents with symptoms of auditory hallucinations, delusions, and formal thought disorder. He was initially treated with risperidone, but his symptoms did not improve after six weeks of treatment. Subsequently, he was switched to olanzapine, but after another six weeks, his symptoms still persisted. What is the next step in the management of this patient?</span></span></p>",
      "unique_key": "Q9658226",
      "question_audio": null,
      "question_video": null,
      "map_id": 9147,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Switch to clozapine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>patient&#39;s symptoms</strong> (auditory hallucinations, delusions, and formal thought disorder) are suggestive of <strong>schizophrenia</strong>. The <strong>lack of response to two adequate trials</strong> (defined as adequate dosages given for 4-6 weeks) of <strong>antipsychotic medications</strong>, such as <strong>risperidone and olanzapine</strong>, indicates <strong><u>treatment-resistant schizophrenia</u></strong>. <strong>Clozapine</strong> is considered the drug of choice in treatment-resistant schizophrenia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Adding a mood stabilizer&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">may be <strong>helpful in cases of schizoaffective disorder</strong> or when there is a comorbid mood disorder.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Switching to a first-generation antipsychotic&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">can be considered, but it is <strong>unlikely to be as effective as clozapine in this case</strong>. However, if the patient refuses to consent to clozapine treatment due to the possibility of adverse effects, a switch to a first-generation antipsychotic is a reasonable option.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Electroconvulsive therapy (ECT)&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">can be <strong>considered for treatment-resistant schizophrenia when other treatment options, including clozapine, have been ineffective</strong> or are not tolerated. However, clozapine should be tried first before considering ECT.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment-resistant Schizophrenia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(TRS) is defined as a <strong>lack of response to two different antipsychotics</strong> given at <strong>adequate dosages</strong> for <strong>adequate duration of 4 to 6 weeks</strong>. <strong>Clozapine</strong> is the <strong>treatment of choice for TRS</strong>.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 190.</span></strong></span></span></p>",
      "correct_choice_id": 35581,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8905,
      "choices": [
        {
          "id": 35587,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue clozapine and monitor the patient closely.</span></span></span></p>"
        },
        {
          "id": 35588,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discontinue clozapine immediately and perform a complete blood count (CBC) with differential.</span></span></span></p>"
        },
        {
          "id": 35589,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop clozapine and order blood tests if the fever doesn&#39;t improve within 48 hours.</span></span></span></p>"
        },
        {
          "id": 35590,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Switch the patient to a different antipsychotic medication.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male with a history schizophrenia has been responding well to clozapine 100 mg daily. Suddenly, he develops high-grade fever. What is the next step in the management of this patient?</span></span></p>",
      "unique_key": "Q9969123",
      "question_audio": null,
      "question_video": null,
      "map_id": 9148,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Discontinue clozapine immediately and perform a complete blood count (CBC) with differential</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>patients taking clozapine</strong>, the <strong>sudden development of high-grade fever is a concerning symptom</strong>, as it may indicate the <strong>onset of agranulocytosis</strong>.&nbsp; In such a clinical scenario, it is essential to <strong>discontinue clozapine immediately and perform a CBC with differential count</strong> to assess the patient&#39;s white blood cell count, particularly the absolute neutrophil count, as agranulocytosis is a potentially life-threatening side effect of clozapine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Continuing clozapine and merely monitoring the patient closely</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>without investigating&nbsp;</strong>the <strong>cause of the fever could put the patient at risk</strong>, given the potential for agranulocytosis with clozapine use.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Waiting 48 hours to order blood tests&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">could <strong>delay the diagnosis and management of a potentially life-threatening condition</strong> such as <strong>agranulocytosis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. While switching the patient to a different antipsychotic medication&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">may be necessary eventually, the <strong>immediate priority is to address the potential cause of the fever, particularly the risk of agranulocytosis.</strong> This requires discontinuing clozapine and performing diagnostic tests.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>development of high-grade fever in a patient taking clozapine warrants immediate discontinuation&nbsp;</strong>of the <strong>drug and prompt investigation for agranulocytosis</strong> through a <strong>complete blood count</strong> (CBC) <strong>with differential</strong>. This is due to clozapine&#39;s known risk of causing agranulocytosis, a potentially life-threatening condition.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schedule for Absolute Neutrophil Count (ANC) monitoring in patients taking clozapine&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Weekly ANC monitoring for the first 6 months</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Every 2 weeks for the next 6 months (months 7-12) if the ANC remains normal</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Every 4 weeks after 1 year of continuous therapy if the ANC remains normal</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 222.</span></strong></span></span></p>",
      "correct_choice_id": 35588,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8911,
      "choices": [
        {
          "id": 35611,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizophrenia</span></span></span></p>"
        },
        {
          "id": 35612,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizoaffective disorder</span></span></span></p>"
        },
        {
          "id": 35613,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute and transient psychotic disorder</span></span></span></p>"
        },
        {
          "id": 35614,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delirium</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23-year-old male presents to the clinic with a two-week history of fever, followed by the acute onset of psychiatric symptoms, including auditory hallucinations (hearing voices), delusions of persecution, disorganized speech, and emotional lability. Prior to this episode, the patient had no history of psychiatric illness, and there is no evidence of substance abuse. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q4677153",
      "question_audio": null,
      "question_video": null,
      "map_id": 9155,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Acute and transient psychotic disorder (ATPD)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this case, the <strong>sudden onset of symptoms including auditory hallucinations</strong>, <strong>delusions of persecution</strong>, <strong>disorganized speech</strong>, and <strong>emotional lability</strong>, after a <strong>period of fever</strong>, is consistent with an <strong>acute and transient psychotic disorder</strong>.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ATPD is characterized by a rapid onset of psychotic symptoms</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> that typically <strong>last for a short duration</strong>, generally <strong>less than one month</strong>. The absence of a previous psychiatric history and evidence of substance abuse further supports this diagnosis. Please, note that <strong>ATPD is usually preceeded by a stressor</strong>, and an <strong>episode of fever can also act as a stressor</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Schizophrenia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To make a <strong>diagnosis of schizophrenia the duration of symptoms should be at least one month</strong> according to ICD-11 and at least 6 months according to DSM-5-TR.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Schizoaffective disorder:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizoaffective disorder is <strong>characterized by a combination of psychotic and mood symptoms</strong>. However, the presentation in this case is more consistent with ATPD due to the sudden onset of symptoms and their short duration.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Delirium:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although <strong>fever can be associated with delirium, the presence of specific psychotic symptoms such as hallucinations and delusions</strong>, along with the <strong>absence of cognitive impairment or altered level of consciousness</strong>, makes ATPD a more likely diagnosis in this case.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute and Transient Psychotic Disorder</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is characterized by the <strong>sudden onset of intense psychotic symptoms</strong>, which are typically <strong>short-lived, lasting from a few days to less than a month.</strong> This condition is distinguished from schizophrenia and schizoaffective disorder by its acute onset and transient nature, and from delirium by the predominance of psychotic symptoms over cognitive disturbances.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Shorter Oxford Textbook of Psychiatry, 7th edition, Page 272-273.&nbsp;</span></strong></span></span></p>",
      "correct_choice_id": 35613,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8913,
      "choices": [
        {
          "id": 35619,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizophrenia</span></span></span></p>"
        },
        {
          "id": 35620,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizoaffective disorder</span></span></span></p>"
        },
        {
          "id": 35621,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delusional disorder</span></span></span></p>"
        },
        {
          "id": 35622,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paranoid personality disorder</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old man presents with a 2-year history of persistently accusing his wife of cheating on him, despite a lack of any evidence to support his claims. He believes his wife is having multiple affairs and has gone to great lengths to track her whereabouts, even installing cameras around their home and constantly demanding that she admit to the alleged affairs. Despite the cameras never capturing any evidence and his children, who live with them, repeatedly attempting to explain the situation, he continues to hold these beliefs. The patient has no history of hallucinations or disorganized speech, and continues to be occupationally productive. Based on this presentation, which diagnosis is most likely?</span></span></p>",
      "unique_key": "Q5832684",
      "question_audio": null,
      "question_video": null,
      "map_id": 9156,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Delusional disorder</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation is most consistent with <strong>delusional disorder</strong>,&nbsp;<u><strong>jealous subtype</strong></u>. In <strong>delusional disorder</strong>, a person has <strong>one or more delusions lasting for at least one month</strong>; other psychotic symptoms like hallucinations, disorganisation, and negative symptoms are&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">usually absent. If hallucinations are present, they are for a very short duration; the presence of frequent hallucinations goes against the diagnosis of delusional disorder. <strong>Apart from the direct impact of delusions</strong>, the <strong>patient&#39;s functioning is not markedly impaired in these patients</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">E.g. the question mentions that the patient remains occupationally productive.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Schizophrenia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and <strong>Option</strong> <strong>B. Schizoaffective disorder:</strong> These options are <strong>less likely due to the absence of other symptoms</strong>, such as <strong>hallucinations, disorganized speech, or negative symptoms</strong>. Additionally, the patient&#39;s overall functioning remains relatively intact, which is atypical for schizophrenia or schizoaffective disorder.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Paranoid personality disorder:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paranoid personality disorder is <strong>characterized by a pattern of unjustified mistrust of others</strong>, typically <strong>beginning in early adulthood</strong>. While this disorder might share some features with delusional disorder, such as suspiciousness and mistrust, the key distinction is the presence of fixed delusions in delusional disorder. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paranoid personality disorder&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">does <strong>not involve the presence of fixed delusions</strong>, but rather a <strong>generalized pattern of suspicion</strong> and <strong>mistrust without specific, persistent beliefs</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Moreover, the onset of paranoid personality disorder is typically earlier in life than the patient&#39;s current age. In this case, the patient&#39;s fixed belief in his wife&#39;s infidelity, despite evidence to the contrary, and the later onset of symptoms point more towards delusional disorder than paranoid personality disorder.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delusional Disorder is characterized by the presence of one or more delusions for at least one month</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Other psychotic symptoms like <strong>hallucinations, disorganisation, and negative symptoms are usually absent</strong>. If hallucinations are present, they are for a very short duration. The individual can function relatively well in daily life except for the disturbances caused directly by the delusions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Ref</u>: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 345.</span></strong></span></span></p>",
      "correct_choice_id": 35621,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8915,
      "choices": [
        {
          "id": 35627,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Capgras Syndrome</span></span></span></p>"
        },
        {
          "id": 35628,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fregoli Syndrome</span></span></span></p>"
        },
        {
          "id": 35629,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Othello Syndrome</span></span></span></p>"
        },
        {
          "id": 35630,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ekbom Syndrome</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old female presents to the psychiatric clinic with concerns about her husband. Over the past few months, she has become increasingly suspicious that her husband has been replaced by an identical-looking imposter. She insists that the person living with her is not her real spouse, although she cannot pinpoint any specific differences in appearance or behavior. She has even collected photographic evidence to prove her claim. Which of the following syndromes best describes her condition?</span></span></p>",
      "unique_key": "Q7024430",
      "question_audio": null,
      "question_video": null,
      "map_id": 9157,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Capgras Syndrome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s belief that her husband has been replaced by an identical-looking imposter is indicative of <strong>Capgras Syndrome</strong>. <strong>Capgras Syndrome</strong> is a <strong>delusional misidentification syndrome</strong> in which a <strong>person holds a delusion that an impostor has replaced a familiar person</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Fregoli Syndrome:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fregoli Syndrome is another <strong>delusional misidentification syndrome</strong>. However, in this condition, the <strong>patient believes that a familiar person can change their physical appearance and disguise as a stranger</strong> and can <strong>take multiple different appearances</strong>. For example, a patient saw a beggar and claimed that his brother was following him in the beggar&#39;s disguise.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Othello Syndrome:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Othello Syndrome, also known as <strong>morbid jealousy or delusional jealousy</strong>, is a <strong>psychiatric condition</strong> in which a <strong>person holds a delusional belief that their spouse or partner is being unfaithful.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ekbom Syndrome:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ekbom Syndrome, also known as <strong>delusional parasitosis, is a psychiatric disorder in which a person falsely believes that they are infested with parasites or insects</strong>.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delusional misidentification syndromes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> include <strong>Capgras syndrome, Fregoli&rsquo;s syndrome, syndrome of intermetamorphosis and syndrome of subjective doubles</strong>.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-143317.jpg\" style=\"height:279px; width:700px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Sim&rsquo;s Symptoms in the Mind, 7th edition, Page No 124-125.</span></strong></span></span></p>",
      "correct_choice_id": 35627,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38081,
      "choices": [
        {
          "id": 152087,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetylcholine and norepinephrine.</span></span></span></p>"
        },
        {
          "id": 152088,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endorphins and enkephalins.</span></span></span></p>"
        },
        {
          "id": 152089,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine and serotonin.</span></span></span></p>"
        },
        {
          "id": 152090,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histamine and oxytocin.</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A third-year medical student is posted in the psychiatry department and is attending a teaching session about schizophrenia. Dr. Patel, a seasoned psychiatrist, is discussing a 25-year-old male patient recently diagnosed with schizophrenia. The patient has been experiencing auditory hallucinations, delusional thinking, and significant social withdrawal. Dr. Patel emphasizes the importance of understanding the neurotransmitter imbalances that underlie the symptoms of schizophrenia, as this understanding can guide treatment. She then poses a question to the medical student: &quot;Which neurotransmitters are primarily implicated in the pathophysiology of schizophrenia?&quot;</span></span></p>",
      "unique_key": "Q9777102",
      "question_audio": null,
      "question_video": null,
      "map_id": 23777,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Dopamine and serotonin.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pathophysiology of schizophrenia is thought to <strong>involve alterations in multiple neurotransmitter systems</strong>. The <strong>two major neurotransmitter systems</strong> implicated in its pathophysiology are <strong>dopamine and serotonin</strong>. <strong>Dopamine hypothesis proposes that excess dopaminergic activity is responsible for schizophrenia</strong>. Along with dopamine, an excess of serotonin is also considered to be responsible for the development of schizophrenia.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Acetylcholine and norepinephrine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is some evidence pointing to their involvement in schizophrenia. However, the <strong>dopamine and serotonin systems are more classically associated with the disease</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Endorphins and enkephalins:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These are <strong>endogenous opioids</strong>, not primarily associated with schizophrenia&#39;s pathophysiology.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Histamine and oxytocin:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While there&#39;s ongoing research into their roles in various conditions, <strong>they aren&#39;t the primary neurotransmitters implicated in schizophrenia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine hypothesis&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">proposes that <strong>excess of dopaminergic activity</strong> is responsible for <strong>schizophrenia</strong>. Along with dopamine, an <strong>excess of serotonin</strong> is also considered to be responsible for the development of schizophrenia. Other <strong>neurotransmitters such as GABA, glutamate, norepinephrine, acetylcholine, nicotine</strong> have also been implicated in pathogenesis of schizophrenia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 361.</span></strong></span></span></p>",
      "correct_choice_id": 152089,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38082,
      "choices": [
        {
          "id": 152091,
          "text": "<p>Frontal lobe</p>"
        },
        {
          "id": 152092,
          "text": "<p>Occipital lobe</p>"
        },
        {
          "id": 152093,
          "text": "<p>Parietal lobe</p>"
        },
        {
          "id": 152094,
          "text": "<p style=\"text-align:justify;\">Temporal lobe</p>"
        }
      ],
      "text": "<p>A 45-year-old patient with a longstanding diagnosis of schizophrenia has been participating in a research study to investigate the neural correlates of the disease. The patient has a prominent history of auditory hallucinations. A magnetic resonance imaging (MRI) scan of the brain is performed. Based on the patient's clinical presentation and the area of the brain commonly associated with these symptoms, which cerebral lobe is most likely to show atrophy in this case?</p>",
      "unique_key": "Q1156511",
      "question_audio": null,
      "question_video": null,
      "map_id": 23778,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><strong>Ans. D) Temporal lobe</strong></p><p><strong>&nbsp;</strong></p><p><strong>Option D:</strong></p><p>&nbsp;</p><p>In chronic schizophrenia, particularly in patients with a significant history of auditory hallucinations and language processing difficulties, atrophy in the temporal lobe is a common finding.&nbsp;</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A: Frontal lobe</strong>. involved in executive function and decision-making, is also commonly affected in schizophrenia but may be more associated with cognitive and negative symptoms of the disorder.</p><p>&nbsp;</p><p><strong>Option B: Occipital lobe and Option C. Parietal lobe</strong> are less commonly associated with atrophy in schizophrenia compared to the frontal and temporal lobes.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Structural and functional abnormalities in the temporal lobe, particularly the superior temporal gyrus, are strongly linked to auditory hallucinations in schizophrenia.&nbsp;</p><p>&nbsp;</p><p><strong>Ref</strong>: Kaplan &amp; Sadockâ€™s Synopsis of Psychiatry, 12th edition.</p>",
      "correct_choice_id": 152094,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38083,
      "choices": [
        {
          "id": 152095,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delusion of persecution</span></span></span></p>"
        },
        {
          "id": 152096,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Somatic passivity</span></span></span></p>"
        },
        {
          "id": 152097,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thought insertion</span></span></span></p>"
        },
        {
          "id": 152098,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thought withdrawal</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year-old man is brought to the psychiatric outpatient department by his concerned parents. They noticed that, over the past few weeks, he has been repeatedly rubbing his forearms and often appears distressed. When asked about this behavior, the patient hesitantly shares that he feels cold sensations running down his forearms. He believes that these sensations are not natural and are deliberately being inflicted upon him by the neighbors living next door. Based on Schneider&rsquo;s first rank symptoms, which one best describes the patient&#39;s experience?</span></span></p>",
      "unique_key": "Q8656685",
      "question_audio": null,
      "question_video": null,
      "map_id": 23779,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Somatic passivity.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schneider&rsquo;s first rank symptoms&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are a <strong>set of symptoms that are highly indicative of schizophrenia.</strong> In the case described, the <strong>patient&#39;s belief</strong> that the <strong>cold sensations on his forearms</strong>, which he <strong>perceives as unnatural and deliberately inflicted upon him by his neighbors</strong>, aligns with the concept of <strong>somatic passivity</strong>. In <strong>somatic passivity</strong>, patients <strong>experience certain somatic hallucinations</strong> which he/she believes are being imposed by an external force or agency.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Delusion of persecution:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This <strong>involves a belief that one is going to be harmed, harassed</strong>, and so <strong>forth by an individual</strong>, organization, or other group.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Thought insertion:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Here, the <strong>patient feels that some external agency is inserting foreign thoughts into his/her mind.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Thought withdrawal:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patient experiences that <strong>his thoughts are being withdrawn from his/her mind by an external force</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-143457.jpg\" style=\"height:504px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Short Textbook of Psychiatry, 7th edition, Page No 55.</span></strong></span></span></p>",
      "correct_choice_id": 152096,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38084,
      "choices": [
        {
          "id": 152099,
          "text": "<p>Autism</p>"
        },
        {
          "id": 152100,
          "text": "<p>Made affect</p>"
        },
        {
          "id": 152101,
          "text": "<p>Association disturbances</p>"
        },
        {
          "id": 152102,
          "text": "<p>Ambivalency</p>"
        }
      ],
      "text": "<p>A 23-year-old individual has been brought to the psychiatric clinic by their family due to increasingly bizarre behavior and disordered thinking observed over the last six months. The patient reports experiencing episodes where their emotions feel controlled by an external force, causing significant distress. The mental status examination does not reveal any prominent mood disorder symptoms, and there is no history of substance abuse. Based on these clinical features, which of the following is most likely a first-rank symptom of schizophrenia in this patient's presentation?</p>",
      "unique_key": "Q4198410",
      "question_audio": null,
      "question_video": null,
      "map_id": 23780,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><strong>Ans. B) Made affect</strong></p><p><strong>&nbsp;</strong></p><p><strong>Option B:</strong></p><p>&nbsp;</p><p>First-rank symptoms of schizophrenia, as described by psychiatrist Kurt Schneider, are specific psychotic symptoms that are highly indicative of schizophrenia, although not exclusive to the disorder.&nbsp;</p><p>&nbsp;</p><p>In this scenario, the patient's experience of their emotions being controlled by an external force is indicative of â€œmade affectâ€.&nbsp; Made affect refers to the feeling that one's emotions or affect are under the control of an external force, is considered as one of the Schneider's first-rank symptoms.&nbsp;</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A</strong>: Autism in the context of schizophrenia refers to excessive fantasy thinking which is irrational and withdrawn behaviour. While this can be present in schizophrenia, it is not considered a first-rank symptom as per Schneiderâ€™s criteria.</p><p>&nbsp;</p><p><strong>Option C</strong>: Association disturbances involve disturbances of association of thoughts such as formal thought disorders and are characteristic of schizophrenia but do not constitute a first-rank symptom.</p><p>&nbsp;</p><p><strong>Option D</strong>: Ambivalency, refers to the marked inability to take a decision, and while it can be associated with schizophrenia, it is not classified as a first-rank symptom.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>In made affect, the patient experiences that someone is controlling his/her affect (emotions). It is consistent with the first-rank symptoms of schizophrenia described by Kurt Schneider.&nbsp;</p><p>&nbsp;</p><p><strong>Ref</strong>: A Short Textbook of Psychiatry, 7th edition.</p>",
      "correct_choice_id": 152100,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38085,
      "choices": [
        {
          "id": 152103,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Her gender being female.</span></span></span></p>"
        },
        {
          "id": 152104,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Receiving her diagnosis at the age of 25.</span></span></span></p>"
        },
        {
          "id": 152105,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The sudden stressor (mother&#39;s death) preceding auditory hallucinations.</span></span></span></p>"
        },
        {
          "id": 152106,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The slow, progressive onset of her symptoms.</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old woman is referred to a psychiatric clinic following several instances of disturbed behavior. Recently, after the unexpected death of her mother, she began reporting auditory hallucinations, particularly voices of the devil and has grown increasingly paranoid, fearing harm from those around her. Detailed assessment uncovers a gradual 3-year decline characterized by her distancing from friends, displaying apathy, and exhibiting odd behaviors, like collecting rainwater to &quot;ward off spirits&quot;. Her father had been treated for major depression. Based on her history, which aspect suggests a potentially unfavorable prognosis for her schizophrenia?</span></span></p>",
      "unique_key": "Q8043337",
      "question_audio": null,
      "question_video": null,
      "map_id": 23781,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) She had an insidious onset of her illness.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As noted, a <strong>gradual, insidious onset</strong> (e.g., the 3-year period of social withdrawal, apathy, and bizarre behavior) <strong>before the emergence of frank psychotic symptoms</strong> often <strong>indicates a poorer prognosis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An <strong>insidious onset</strong>, characterized by a <strong>gradual decline before the appearance of psychotic symptoms</strong>, is associated with a <strong>poorer outcome compared to an acute onset</strong> precipitated by a stressful event.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: She is female: </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Female gender&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is generally <strong>associated with a better prognosis</strong> in schizophrenia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: She was age 25 at diagnosis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>younger age</strong> at the time of diagnosis (e.g., adolescence) is often <strong>associated with a poorer prognosis</strong>. Age 25 is not necessarily indicative of a particularly poor prognosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: She had an acute precipitating factor before she began hearing voices:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An <strong>acute onset of symptoms after a significant stressor</strong> or <strong>life event tends to be associated with a better prognosis.</strong> In this patient, the death of her mother could be such a precipitating factor.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An <strong>insidious onset</strong>, <strong>prominent negative symptoms</strong>, <strong>poor premorbid adjustment</strong>, and <strong>absence of precipitating factors</strong> are among features typically <strong>associated with a worse prognosis in schizophrenia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-144108.jpg\" style=\"height:288px; width:700px\" /></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 350.</span></strong></span></span></p>",
      "correct_choice_id": 152106,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38086,
      "choices": [
        {
          "id": 152107,
          "text": "<p>Homicide is the most common cause of premature death</p>"
        },
        {
          "id": 152108,
          "text": "<p>Lifetime prevalence is 0.7&nbsp;%</p>"
        },
        {
          "id": 152109,
          "text": "<p>Catatonic schizophrenia is associated with the best prognosis</p>"
        },
        {
          "id": 152110,
          "text": "<p>Negative symptoms are associated with poor prognosis</p>"
        }
      ],
      "text": "<p>Which of the following is not true regarding schizophrenia?</p>",
      "unique_key": "Q1363648",
      "question_audio": null,
      "question_video": null,
      "map_id": 23782,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><strong>Ans. A) Homicide is the most common cause of premature death</strong></p><p><strong>&nbsp;</strong></p><p><strong>Option A:</strong></p><p><strong>&nbsp;</strong></p><p>The most common cause of premature death in schizophrenia is not homicide. Suicide is the most common cause of premature death in these individuals.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B: Lifetime prevalence is 0.7 %</strong>: This is true. The lifetime prevalence of schizophrenia is estimated to be about 0.7 % in the general population worldwide.</p><p>&nbsp;</p><p><strong>Option C: Catatonic schizophrenia is associated with the best prognosis</strong>: This is true. Among the various subtypes of schizophrenia, the catatonic subtype is often associated with a best prognosis. Subtypes of schizophrenia has been removed from DSM-5 and ICD-11. Catatonia is now considered as a distinct diagnostic entity.</p><p>&nbsp;</p><p><strong>Option D: Negative symptoms are associated with poor prognosis</strong>: This is also true. Negative symptoms, such as anhedonia, alogia, and social withdrawal, often indicate a more chronic course and are typically harder to treat than positive symptoms.</p><p>&nbsp;</p><p><strong>Educational Objective:&nbsp;</strong></p><p>&nbsp;</p><p>Suicide is the most common cause of premature death in persons suffering from schizophrenia. 10% of patients with schizophrenia die by suicide (DSM-5 figure: 5-6%)</p><p>&nbsp;</p><p><strong>Ref</strong>: Kaplan &amp; Sadockâ€™s Synopsis of Psychiatry, 12th edition</p>",
      "correct_choice_id": 152107,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38087,
      "choices": [
        {
          "id": 152111,
          "text": "<p>Drug-induced Parkinsonism</p>"
        },
        {
          "id": 152112,
          "text": "<p>Negative symptoms of a psychiatric disorder</p>"
        },
        {
          "id": 152113,
          "text": "<p>Depression</p>"
        },
        {
          "id": 152114,
          "text": "<p>Reaction to active hallucinations</p>"
        }
      ],
      "text": "<p>A 26-year-old female presents to the psychiatric clinic complaining of a progressively declining interest in attending her job over the past month. Upon review of her medical records, it is noted that she has previously been treated with risperidone and demonstrated significant clinical improvement. She currently denies any auditory or visual hallucinations. Physical examination shows no evidence of tremor, rigidity, or bradykinesia. Based on the patient's history and presentation, which of the following is the MOST likely explanation for her decreased interest in work?</p>",
      "unique_key": "Q7329409",
      "question_audio": null,
      "question_video": null,
      "map_id": 23783,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><strong>Ans. B) Negative symptoms of a psychiatric disorder</strong></p><p><strong>&nbsp;</strong></p><p><strong>Option B:</strong></p><p>&nbsp;</p><p>The patient's history of risperidone treatment suggests a prior psychotic disorder, likely schizophrenia. Schizophrenia includes both positive (e.g., hallucinations) and negative symptoms. The latter, such as avolition, manifest as decreased motivation or interest, like her decreased work interest.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A</strong>: Drug-induced Parkinsonism from antipsychotics would present with tremor, rigidity, and bradykinesia, which she lacks.</p><p>&nbsp;</p><p><strong>Option C: Depression</strong>: While depression can decrease work interest, her prior response to risperidone and lack of other depressive symptoms points more towards negative symptoms.</p><p>&nbsp;</p><p><strong>Option D: Reaction to active hallucinations</strong>: She denies active hallucinations, making this choice less likely.</p><p>&nbsp;</p><p><strong>Educational Objective:&nbsp;</strong></p><p>&nbsp;</p><p>Negative symptoms represent â€œloss of normal functionsâ€ in patients with&nbsp; These symptoms respond poorly to medications and thus their presence is a bad prognostic factor. They occur due to decreased dopamine activity in mesocortical pathway. While anhedonia (loss of pleasure in previously pleasurable activities) is a symptom of both depression and schizophrenia, the absence of other key depressive symptoms and the history of treatment with an antipsychotic make negative symptoms of schizophrenia more likely.</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Kaplan &amp; Sadockâ€™s Synopsis of Psychiatry, 12th edition</span></p>",
      "correct_choice_id": 152112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38170,
      "choices": [
        {
          "id": 152443,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sertraline</span></span></span></p>"
        },
        {
          "id": 152444,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clozapine</span></span></span></p>"
        },
        {
          "id": 152445,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diazepam</span></span></span></p>"
        },
        {
          "id": 152446,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risperidone</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old woman with a chronic mental disorder comes to the physician with irregular choreoathetoid movements of her hands and trunk. She states that the movements get worse under stressful conditions. Which of the following medications is most likely to have caused this disorder?</span></span></p>",
      "unique_key": "Q7177763",
      "question_audio": null,
      "question_video": null,
      "map_id": 23866,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Risperidone.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong>&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An <strong>atypical antipsychotic</strong>. Even though <strong>atypical antipsychotics</strong> have a <strong>lower risk of causing tardive dyskinesia</strong> compared to <strong>typical antipsychotics</strong>, they are <strong>not devoid of the risk</strong>. Risperidone, in particular, has a relatively higher risk among the atypical antipsychotics.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>patient&#39;s presentation of irregular choreoathetoid movements</strong>, particularly of <strong>her hands and trunk</strong>, is suggestive of <strong>tardive dyskinesia</strong> (TD). Tardive dyskinesia is a movement disorder that is associated with long-term use of certain medications, particularly the typical (first-generation) and atypical (second-generation) antipsychotic drugs.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Sertraline:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An SSRI antidepressant mainly <strong>used for depression and various anxiety disorders</strong>. It is not primarily associated with tardive dyskinesia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Clozapine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An <strong>atypical antipsychotic</strong> that is <strong>least likely to cause tardive dyskinesia compared to other antipsychotic medications</strong>. In fact, clozapine can sometimes reduce TD that is caused by other antipsychotic medications.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Diazepam:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A benzodiazepine primarily used for <strong>anxiety, seizures, and muscle spasms</strong>. It is not associated with the development of tardive dyskinesia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tardive dyskinesia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">develops after <strong>long-term treatment with antipsychotics and is characterized by involuntary choreoathetoid movements of the tongue, jaw, lips, trunk or extremities</strong>. Risk factors for developing TD include <strong>older age, female sex, and long duration of antipsychotic use</strong>. The primary prevention of TD involves using the lowest effective dose of antipsychotic and regularly monitoring patients. If a patient develops symptoms of TD, it&#39;s important to consider discontinuing the antipsychotic or switching to one with a lower risk for TD, such as clozapine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</span></strong></span></span></p>",
      "correct_choice_id": 152446,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38171,
      "choices": [
        {
          "id": 152447,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Depot medications are useful in cases of non-compliance&nbsp;</span></span></span></p>"
        },
        {
          "id": 152448,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They undergo less first-pass metabolism than oral preparations&nbsp;</span></span></span></p>"
        },
        {
          "id": 152449,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Injection site reactions are a side-effect&nbsp;</span></span></span></p>"
        },
        {
          "id": 152450,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All antipsychotic depot preparations are oil based</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Regarding depot preparations, which of the following statements is FALSE?&nbsp;</span></span></p>",
      "unique_key": "Q5826830",
      "question_audio": null,
      "question_video": null,
      "map_id": 23867,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) All antipsychotic depot preparations are oil based.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The statement that &quot;<strong>All antipsychotic depot preparations are oil based</strong>&quot; is <strong>FALSE</strong>. While many <strong>antipsychotic depot preparations are oil-based to allow for slow release of the medication over time</strong>, not all depot preparations are formulated this way. Advances in <strong>pharmaceutical technology</strong> have led to the <strong>development of various formulations, microsphere-based depots</strong> (e.g., paliperidone palmitate).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Depot medications are useful in cases of non-compliance: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>true</strong>. Depot antipsychotics are particularly useful in managing patients who have difficulty adhering to oral medication regimens.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: They undergo less first-pass metabolism than oral preparations:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is also <strong>true</strong>. Depot injections bypass the gastrointestinal tract and thus avoid first-pass metabolism in the liver. This can result in more stable and predictable pharmacokinetics.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Injection site reactions are a side-effect:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>true</strong>. Injection site reactions, such as pain, redness, and swelling, are potential side effects of depot antipsychotic medications.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Depot antipsychotic preparations&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are useful for <strong>ensuring compliance</strong>, especially in <strong>patients who may have difficulty adhering to a daily oral regimen</strong>. The patients typically receive the <strong>intramuscular injections</strong> of antipsychotics once a month or once in a fortnight.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 67.</span></strong></span></span></p>",
      "correct_choice_id": 152450,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38172,
      "choices": [
        {
          "id": 152451,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pulmonary embolism&nbsp;</span></span></span></p>"
        },
        {
          "id": 152452,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paralytic ileus&nbsp;</span></span></span></p>"
        },
        {
          "id": 152453,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agranulocytosis&nbsp;</span></span></span></p>"
        },
        {
          "id": 152454,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myocarditis</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most probable diagnosis in a clozapine-treated patient who has persistent tachycardia, fatigue, fever, and eosinophilia is:&nbsp;</span></span></p>",
      "unique_key": "Q8113190",
      "question_audio": null,
      "question_video": null,
      "map_id": 23868,
      "difficulty_level": "difficult",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Myocarditis.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clozapine&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">has been <strong>associated with myocarditis,</strong> especially during the <strong>first two months of treatment.</strong>&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s symptoms of <strong>persistent tachycardia, fatigue, fever, and eosinophilia</strong> after being <strong>treated with clozapine are suggestive of myocarditis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Pulmonary embolism:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While this can <strong>cause tachycardia and fatigue</strong>, it is <strong>not typically associated with fever and eosinophilia.</strong>&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Paralytic ileus:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This would primarily present with <strong>symptoms related to bowel obstruction such as abdominal distension and constipation.</strong> It&#39;s not associated with tachycardia, fever, and eosinophilia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Agranulocytosis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a <strong>well-known side effect of clozapine</strong>, but it presents with a <strong>decrease in white blood cells</strong>, especially <strong>neutrophils</strong>, and would not cause eosinophilia. Patients with agranulocytosis may have fever, sore throat, and increased susceptibility to infections.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clozapine is the drug of choice in treatment-resistant schizophrenia.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It has <strong>strong affinity towards D4 and low affinity towards D2</strong>, which explains the <strong>lack of extrapyramidal side effects</strong>. It also acts as an antagonist at 5 HT2A, D1, D3 and </span><span style=\"font-family:&quot;Cambria Math&quot;,serif\">âº</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">-adrenergic receptors. Clozapine is the only antipsychotic that <strong>decreases </strong>the <strong>suicidal ideation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-144402.jpg\" style=\"height:328px; width:700px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 222-224.</span></strong></span></span></p>",
      "correct_choice_id": 152454,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38173,
      "choices": [
        {
          "id": 152455,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aripiprazole</span></span></span></p>"
        },
        {
          "id": 152456,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Olanzapine</span></span></span></p>"
        },
        {
          "id": 152457,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Quetiapine</span></span></span></p>"
        },
        {
          "id": 152458,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risperidone</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 29-year-old woman with a history of Schizophrenia is being seen in the clinic for a medication review. She has been stable on her current medication but is concerned about her recent weight gain of 15 pounds over the past 6 months. She is conscious about her weight and does not want any medication that might exacerbate this issue. She inquires about potential antipsychotic medications that might be less likely to cause weight gain. Which of the following antipsychotics would be the best recommendation for this patient if considering the potential for weight gain?</span></span></p>",
      "unique_key": "Q9259446",
      "question_audio": null,
      "question_video": null,
      "map_id": 23869,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Aripiprazole.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aripiprazole&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is known for having a <strong>lower risk of causing weight gain compared to other antipsychotics.</strong> In patients who are <strong>concerned about weight gain</strong> or <strong>metabolic side effects</strong>, <strong>aripiprazole</strong> is often considered a <strong>good choice due to its more favorable metabolic profile</strong>. It is effective in managing symptoms of schizophrenia while minimizing the risk of significant weight gain and other metabolic disturbances.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Olanzapine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with <strong>significant weight gain</strong>, as well as other metabolic side effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Quetiapine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Can cause <strong>moderate weight gain</strong>, though not as much as olanzapine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Risperidone:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Can also <strong>lead to weight gain</strong>, but generally less than olanzapine and quetiapine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:&nbsp;</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PATHOPHYSIOLOGY OF ANTIPSYCHOTIC INDUCED WEIGHT GAIN</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/flow-chart-2_WYr6DHY.jpg\" style=\"height:296px; width:400px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aripiprazole&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and <strong>ziprasidone</strong> are <strong>two antipsychotics</strong> with a relatively <strong>lower risk of weight gain compared to others</strong>. Olanzapine and clozapine are most associated with weight gain.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 123.</span></strong></span></span></p>",
      "correct_choice_id": 152455,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38175,
      "choices": [
        {
          "id": 152463,
          "text": "<p>5 years</p>"
        },
        {
          "id": 152464,
          "text": "<p>2 years</p>"
        },
        {
          "id": 152465,
          "text": "<p>6 months</p>"
        },
        {
          "id": 152466,
          "text": "<p>1 year</p>"
        }
      ],
      "text": "<p>A 23-year-old male presents to the outpatient clinic for a follow-up visit. He was diagnosed with schizophrenia 2 months ago after experiencing auditory hallucinations and delusional beliefs. His symptoms have significantly improved with risperidone, and he currently reports feeling more \"like himself\" again. His family and social histories are unremarkable, with no known relatives with psychiatric disorders. The patient, eager to move on with his life, inquires about the duration for which he will need to continue his medication. What is the recommended treatment duration for this patient?</p>",
      "unique_key": "Q1512144",
      "question_audio": null,
      "question_video": null,
      "map_id": 23871,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><strong>Ans. D) 1 years.</strong></p><p>&nbsp;</p><p><strong>Option D:</strong></p><p>&nbsp;</p><p>In the context of a first episode of schizophrenia that has responded well to antipsychotic treatment, the current Edition of Synaposis (12th Edition) typically recommend continuation of the antipsychotic medication for 1 Year.&nbsp;</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A: 5 years</strong>: This duration is typically more applicable to individuals who have had multiple episodes of schizophrenia or other high-risk factors for recurrence, which the patient doesn't have.</p><p>&nbsp;</p><p><strong>Option B: 2 year</strong>: While earlier guidelines do mention a minimum of 2 year to provide a safer margin to reduce the risk of early relapse, especially when there's been a good response to the medication, but recent synopsis(12th Edition) mentions 1 year prophylxis</p><p>&nbsp;</p><p><strong>Option C: 6 months</strong>: This duration might be too short and could increase the risk of relapse. After a first episode, it's crucial to ensure stability for a more extended period.</p><p>&nbsp;</p><p><strong>Educational objective:&nbsp;</strong></p><p>&nbsp;</p><p>Typically, antipsychotic medication should be continued for 1&nbsp; &nbsp; &nbsp; year&nbsp; &nbsp; &nbsp; following a first episode of schizophrenia, especially when there has been a favorable response to the treatment.&nbsp;</p><p>&nbsp;</p><p><strong>Ref</strong>: Kaplan &amp; Sadockâ€™s Synopsis of Psychiatry, 12th edition.â€ƒ</p>",
      "correct_choice_id": 152466,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38176,
      "choices": [
        {
          "id": 152467,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Haloperidol</span></span></span></p>"
        },
        {
          "id": 152468,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clonidine</span></span></span></p>"
        },
        {
          "id": 152469,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol</span></span></span></p>"
        },
        {
          "id": 152470,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lorazepam</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old patient with a history of psychosis is brought to the medical attention due to the exhibition of erratic behavior, characterized by purposeless movements. Additionally, the healthcare team observes episodes where the patient remains immobile for prolonged durations. Upon physical examination, the patient demonstrates negativism and waxy flexibility. Based on these clinical findings, what is the most appropriate pharmacological intervention for managing this patient&#39;s condition?</span></span></p>",
      "unique_key": "Q6311938",
      "question_audio": null,
      "question_video": null,
      "map_id": 23872,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Lorazepam</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>patient&#39;s presentation of purposeless movements</strong>, <strong>prolonged immobility</strong>, <strong>negativism, and waxy flexibility</strong> is indicative of <strong>catatonia</strong>. <strong>D) Lorazepam (intravenous)</strong> is considered the first-line treatment for catatonia.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Haloperidol&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an <strong>antipsychotic medication</strong> that could <strong>potentially exacerbate catatonic symptoms</strong> and is generally avoided, especially in the initial management of catatonia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Clonidine&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an <strong>alpha-2 adrenergic agonist</strong> primarily used for <strong>treating hypertension</strong> and is not indicated for the treatment of catatonia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Propranolol&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>beta-blocker used for treating hypertension, anxiety, and akathisia</strong> but is not the treatment of choice for catatonia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The term <strong>catatonia</strong> was given by <strong>Karl Kahlbaum</strong>. Catatonia is a <strong>psychiatric emergency</strong> that is characterized by <strong>severe motor abnormalities</strong> such as <strong>akinetic mutism</strong> (stupor), <strong>excitement</strong>, <strong>waxy flexibility</strong>, <strong>posturing</strong>, <strong>catalepsy</strong>, <strong>automatic obedience</strong>, <strong>negativism</strong>, <strong>Gegenhalten</strong>, psychological pillow etc. The lorazepam challenge test aids in prompt diagnosis. <strong>Lorazepam </strong>is<strong> first line treatment </strong>for catatonia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 11th edition, Page No 345-346.</span></strong></span></span></p>",
      "correct_choice_id": 152470,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38177,
      "choices": [
        {
          "id": 152471,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dissociative amnesia&nbsp;</span></span></span></p>"
        },
        {
          "id": 152472,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transient global amnesia&nbsp;</span></span></span></p>"
        },
        {
          "id": 152473,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Catatonia&nbsp;</span></span></span></p>"
        },
        {
          "id": 152474,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Panic disorder</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The lorazepam challenge test is used in the diagnosis of?</span></span></span></p>",
      "unique_key": "Q5392902",
      "question_audio": null,
      "question_video": null,
      "map_id": 23873,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Catatonia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>lorazepam challenge test</strong> is used in the diagnosis of <strong>catatonia</strong>. The <strong>lorazepam challenge test</strong> involves <strong>administering intravenous lorazepam</strong> (1-2 mg) to the <strong>patient and observing for a rapid improvement in symptoms</strong>. A positive response to lorazepam is considered indicative of catatonia and can guide further management of the condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Dissociative amnesia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosed <strong>clinically based on the inability to recall important personal information</strong>, usually of a traumatic or stressful nature.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Transient global amnesia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A sudden, <strong>temporary episode of memory loss</strong>; diagnosis is clinical, based on history and exclusion of other conditions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Panic disorder:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosed <strong>based on recurrent</strong>, <strong>unexpected panic attacks</strong> and the fear of further attacks.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>lorazepam challenge test</strong> is used in the <strong>diagnosis of catatonia</strong>. It involves <strong>administering lorazepam intravenously</strong> (1-2 mg) and observing for a <strong>reduction in catatonic symptoms</strong>, which usually <strong>takes 30 minutes</strong>.&nbsp; It can aid the diagnosis and guide subsequent treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 11th edition, Page No 345-346.</span></strong></span></span></p>",
      "correct_choice_id": 152473,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38179,
      "choices": [
        {
          "id": 152479,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administering long acting antipsychotic</span></span></span></p>"
        },
        {
          "id": 152480,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithium monitoring</span></span></span></p>"
        },
        {
          "id": 152481,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbamazepine monitoring</span></span></span></p>"
        },
        {
          "id": 152482,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nicotine patch</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In clinical practice, the Z-tracking technique is a specific method employed for a particular type of intervention. Which of the following scenarios is the Z-tracking technique most commonly used?</span></span></p>",
      "unique_key": "Q6280116",
      "question_audio": null,
      "question_video": null,
      "map_id": 23875,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Administering long acting antipsychotic</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Z-track technique</strong> is a method used to <strong>administer intramuscular injections</strong>. This technique is most commonly used for administering<strong> long acting antipsychotic injections</strong>, also known as <strong>depot antipsychotics.</strong> These are typically used for patients with schizophrenia or other psychotic disorders to ensure adherence to medication and provide a steady level of medication in the bloodstream.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Lithium monitoring&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">refers to the <strong>regular blood tests required to check lithium levels in patients taking lithium for mood stabilization</strong>, particularly in bipolar disorder. The Z-track method is not applicable in this scenario.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Carbamazepine monitoring&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is similar to <strong>lithium monitoring</strong> in that it <strong>involves blood tests to monitor medication levels</strong> and <strong>ensure they are within the therapeutic range</strong>. Again, the Z-track method is not used in this context.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Nicotine patch&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">refers to a <strong>transdermal patch used to deliver nicotine as part of smoking cessation therapy.</strong> The Z-track technique is not relevant to the application of transdermal patches.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Z-track technique is a method used to administer intramuscular injections</strong>, which is <strong>particularly useful for medications</strong> that can be <strong>irritating to subcutaneous tissue</strong> or have the <strong>potential to discolor the skin</strong>. It also <strong>prevents the medication from leaking into the patient&rsquo;s subcutaneous tissue</strong> which can cause <strong>erratic absorption</strong>. It involves <strong>pulling the skin and subcutaneous tissues</strong> to <strong>one side before inserting the needle into the muscle</strong>. After injecting the medication, the needle is removed, and the skin is released, creating a zigzag path that seals the medication in the muscle and prevents it from leaking into the subcutaneous tissue. This technique is most commonly used for administering<strong> depot antipsychotics.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 67.</span></strong></span></span></p>",
      "correct_choice_id": 152479,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38180,
      "choices": [
        {
          "id": 152483,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute dystonia</span></span></span></p>"
        },
        {
          "id": 152484,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Akathisia</span></span></span></p>"
        },
        {
          "id": 152485,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neuroleptic malignant syndrome</span></span></span></p>"
        },
        {
          "id": 152486,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tardive dyskinesia</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 21-year-old man is brought to the clinic by his mother, who reports a sudden and concerning change in his posture. The boy was recently started on an antipsychotic medication by his psychiatrist. On examination, you observe that his head and neck are twisted to one side, resembling a torticollis. His vitals are stable, and no other neurological or systemic symptoms are present. Which of the following is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q7255975",
      "question_audio": null,
      "question_video": null,
      "map_id": 23876,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Acute dystonia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation of <strong>sudden onset torticollis after starting an antipsychotic drug is consistent with acute dystonia</strong>. <strong>Acute dystonia</strong> is a type of <strong>extrapyramidal symptom</strong> (EPS) that can occur <strong>following the administration of antipsychotic medications</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Akathisia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>subjective feeling of inner restlessness</strong> along with <strong>objective signs of restlessness such as fidgeting of legs</strong>,&nbsp;&nbsp;<strong>pacing around</strong>, and <strong>inability to sit or stand</strong> in one place for a long time. It doesn&#39;t manifest as torticollis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Neuroleptic malignant syndrome</strong> is a <strong>life-threatening reaction to antipsychotic drugs</strong> characterized by <strong>fever, autonomic instability, altered mental status, and generalized muscle rigidity</strong>. It doesn&#39;t typically present solely with torticollis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tardive dyskinesia</strong> is a <strong>late-onset EPS</strong>, which <strong>presents as involuntary, repetitive movements,</strong> <strong>often of the mouth, lips, and tongue</strong>. It usually occurs after prolonged use of antipsychotic medications and not shortly after the initiation of therapy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute dystonia is the <strong>earliest side effect </strong>of <strong>antipsychotics</strong> can be seen within <strong>minutes of receiving an injectable antipsychotic</strong> (also with oral antipsychotic). It is characterized by <strong>sudden contraction </strong>of a muscle group and can lead to symptoms like <strong>torticollis</strong> (twisting of the neck), <strong>oculogyric crisis</strong> (deviation of eyeballs), <strong>opisthotonos</strong> (extreme arching of the back), trismus (contraction of jaw muscles) or other dystonic reactions.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</span></strong></span></span></p>",
      "correct_choice_id": 152483,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38181,
      "choices": [
        {
          "id": 152487,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lorazepam</span></span></span></p>"
        },
        {
          "id": 152488,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol</span></span></span></p>"
        },
        {
          "id": 152489,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trihexyphenidyl</span></span></span></p>"
        },
        {
          "id": 152490,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tetrabenazine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old patient with a diagnosis of schizophrenia, who is currently being treated with trifluoperazine, has developed a recent onset of rigidity and tremors. Based on the clinical presentation, which of the following is the most appropriate intervention to manage these symptoms?</span></span></span></p>",
      "unique_key": "Q9332503",
      "question_audio": null,
      "question_video": null,
      "map_id": 23877,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Trihexyphenidyl</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&rsquo;s symptoms of <strong>rigidity and tremors on trifluoperazine</strong> are suggestive of <strong>drug-induced parkinsonism. </strong>These <strong>symptoms arise due to dopamine blockade in the nigrostriatal pathway</strong>. <strong>C) Trihexyphenidyl</strong>, an <strong>anticholinergic medication</strong>, is used to treat these <strong>Parkinsonian symptoms</strong> by restoring the balance of acetylcholine and dopamine in the central nervous system. Thus, it helps in alleviating symptoms like rigidity and tremors.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Lorazepam&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is <strong>not the primary treatment for drug-induced parkinsonism</strong>. It can be useful in catatonia or acute dystonia but is not the optimal choice for this patient&rsquo;s presentation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Propranolol&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>beta-blocker primarily used for akathisia</strong> and is not used to treat drug-induced parkinsonism.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Tetrabenazine&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is used to <strong>treat hyperkinetic movement disorders such as Huntington&rsquo;s disease and tardive dyskinesia</strong> and is not indicated for drug-induced parkinsonism. In fact, it could potentially worsen the patient&#39;s symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug induced parkinsonism&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is characterized by the <strong>triad of rigidity, bradykinesia and resting tremors</strong> (3-6 Hz). The treatment options include use of <strong>anticholinergics</strong> (e.g., trihexyphenidyl, diphenhydramine) or <strong>change of antipsychotics to â€‹â€‹second generation or low potency first generation antipsychotics.</strong> The dose reduction can also be tried. Often, use of prophylactic anticholinergics prevents the development of drug induced parkinsonism.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</span></strong></span></span></p>",
      "correct_choice_id": 152489,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38182,
      "choices": [
        {
          "id": 152491,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Olanzapine</span></span></span></p>"
        },
        {
          "id": 152492,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chlorpromazine</span></span></span></p>"
        },
        {
          "id": 152493,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Quetiapine</span></span></span></p>"
        },
        {
          "id": 152494,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amisulpride</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following agents is associated with maximum metabolic side effects and least extrapyramidal side effects?&nbsp;</span></span></p>",
      "unique_key": "Q5750335",
      "question_audio": null,
      "question_video": null,
      "map_id": 23878,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Olanzapine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the options provided, <strong>olanzapine is associated with the highest risk of metabolic side effects</strong>, including <strong>weight gain, diabetes mellitus, and dyslipidemia.</strong> At the same time, olanzapine has a relatively <strong>lower risk of causing extrapyramidal side effects</strong> (EPS) compared to some of the other antipsychotics.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chlorpromazine</strong> is a <strong>first-generation</strong> (typical) <strong>antipsychotic</strong> and is associated with a <strong>higher risk of extrapyramidal side effects</strong> compared to olanzapine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Quetiapine</strong> has <strong>metabolic side effects</strong>, though typically not as pronounced as olanzapine. Its risk for EPS is also relatively low.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Amisulpride</strong> is an <strong>atypical antipsychotic</strong> with a <strong>more pronounced risk for extrapyramidal side effects</strong> compared to olanzapine and quetiapine. Its metabolic side effect profile is less than that of olanzapine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metabolic side effects&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are seen more with <strong>atypical than typical antipsychotics</strong>, due to their <strong>H1 antagonism and 5HT2C antagonism.</strong> It is seen most with <strong>clozapine followed by olanzapine.</strong> Extrapyramidal side effects, on the other hand, are seen more with typical than atypical antipsychotics. <strong>Clozapine is least associated with EPS</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 109, 123.&nbsp;</span></strong></span></span></p>",
      "correct_choice_id": 152491,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38183,
      "choices": [
        {
          "id": 152495,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Penfluriodl</span></span></span></p>"
        },
        {
          "id": 152496,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lurasidone</span></span></span></p>"
        },
        {
          "id": 152497,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluphenazine</span></span></span></p>"
        },
        {
          "id": 152498,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithium</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 29-year-old male with a confirmed diagnosis of schizophrenia has been undergoing treatment with haloperidol. While there is a noticeable improvement in the positive symptoms of his condition, he has concurrently developed troubling side effects, including akathisia and dystonia. Given this clinical scenario, which of the following pharmacological agents would be most beneficial to address his current needs?</span></span></p>",
      "unique_key": "Q5269551",
      "question_audio": null,
      "question_video": null,
      "map_id": 23879,
      "difficulty_level": "difficult",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Lurasidone</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lurasidone&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an <strong>atypical antipsychotic that is associated with a lower risk</strong> of <strong>extrapyramidal symptoms</strong> (EPS) such as <strong>akathisia and dystonia compared to typical antipsychotics like haloperidol</strong>. Since the patient has developed EPS side effects while on haloperidol, switching to an atypical antipsychotic with a more favorable side effect profile, such as lurasidone, would be a beneficial strategy.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Penfluridol&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and <strong>C. Fluphenazine</strong> are <strong>both typical antipsychotics,</strong> like <strong>haloperidol</strong>, and are likely to <strong>carry a similar risk of EPS</strong>. Therefore, they would not be the best choices for this patient given the side effects he is experiencing.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Lithium&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is primarily <strong>used to treat bipolar disorder and is not typically used as monotherapy for schizophrenia</strong>, especially when the concern is managing EPS.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lurasidone&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">presents a <strong>lower risk of EPSE</strong> while effectively managing the <strong>positive symptoms of schizophrenia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 614-615.</span></strong></span></span></p>",
      "correct_choice_id": 152496,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38184,
      "choices": [
        {
          "id": 152499,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neuroleptic malignant syndrome.</span></span></span></p>"
        },
        {
          "id": 152500,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Restless leg syndrome.</span></span></span></p>"
        },
        {
          "id": 152501,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute akathisia.</span></span></span></p>"
        },
        {
          "id": 152502,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tardive dyskinesia.</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman presents to the emergency department with her mother, who expresses concern about her daughter&#39;s inability to remain stationary over the past week, noting excessive leg movement. The patient was recently started on risperidone for newly diagnosed schizophrenia. Since then, she has been unable to sit still and constantly feels the need to move. She describes a subjective feeling of inner restlessness, compelling her to walk around and shift her weight from one foot to the other when standing. She has no history of substance abuse, and there are no signs of intoxication. Her vital signs are within normal limits, and neurological examination does not reveal any abnormal movements like tremors or rigidity. Which of the following is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q5990560",
      "question_audio": null,
      "question_video": null,
      "map_id": 23880,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Acute akathisia.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation of <strong>subjective inner restlessness</strong> along with <strong>objective signs of restlessness</strong> such as <strong>pacing around and fidgeting</strong> especially after being started on <strong>risperidone</strong> (an antipsychotic), is consistent with <strong>acute akathisia</strong>.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Neuroleptic malignant syndrome</strong> is a <strong>life-threatening reaction to antipsychotic drugs</strong> characterized by fever, autonomic dysfunction, altered mental status, and generalized muscle rigidity.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Restless leg syndrome</strong> is an <strong>urge to move the legs, usually accompanied by uncomfortable sensations</strong>, which typically worsen at night and are relieved by movement.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tardive dyskinesia</strong> is a <strong>late-appearing side effect of antipsychotic medications</strong> characterized by repetitive, involuntary, and purposeless movements, often of the mouth, lips, and tongue (like lip-smacking or chewing).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute akathisia is the <strong>commonest side effect</strong> of antipsychotic medications. It is characterized by an <strong>inner sense of restlessness</strong> along with <strong>objective</strong>, <strong>observable movements</strong> such as <strong>fidgeting</strong> of legs, <strong>pacing around</strong>, <strong>inability to sit</strong> or <strong>stand</strong> in one place for a long time. <strong>Drug of choice </strong>is <strong>&beta;-blockers</strong> such as propranolol. Other treatment options include <strong>anticholinergics </strong>and <strong>benzodiazepines</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.&nbsp;</span></strong></span></span></p>",
      "correct_choice_id": 152501,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38185,
      "choices": [
        {
          "id": 152503,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct stimulation of the anterior pituitary gland by the antipsychotic.</span></span></span></p>"
        },
        {
          "id": 152504,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Induction of hypothalamic hormones stimulating prolactin production.</span></span></span></p>"
        },
        {
          "id": 152505,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease in serotonin-mediated prolactin release.</span></span></span></p>"
        },
        {
          "id": 152506,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blockade of dopamine D<sub>2</sub> receptors in tuberoinfundibular tract leading to increased prolactin release.&nbsp;</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 29-year-old man with schizophrenia presents to the outpatient psychiatric clinic with concerns about recently developed breast enlargement and tenderness. He states that he has been adhering to his medication regimen, which includes risperidone.&nbsp; His psychiatrist explains that some antipsychotic medications can lead to elevated prolactin levels, which can cause such symptoms. Curious, the patient asks about how the medication leads to this change. Which of the following best explains the pathophysiology behind antipsychotic-induced hyperprolactinemia?</span></span></p>",
      "unique_key": "Q7163517",
      "question_audio": null,
      "question_video": null,
      "map_id": 23881,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Blockade of dopamine D2 receptors in tuberoinfundibular tract leading to increased prolactin release.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolactin secretion&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">from the <strong>anterior pituitary is primarily regulated by dopamine</strong>, which is <strong>inhibitory</strong>. <strong>Dopamine</strong> travels from the <strong>hypothalamus to the anterior pituitary</strong> via the <strong>tuberoinfundibular tract</strong>. Most <strong>antipsychotic medications</strong>, including <strong>risperidone, block dopamine D2 receptors</strong>. By blocking D2 receptors in the tuberoinfundibular tract, these medications reduce the inhibitory effect of dopamine on prolactin secretion, leading to hyperprolactinemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Antipsychotics</strong> <strong>do not directly stimulate the anterior pituitary gland</strong> to release prolactin.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antipsychotics do not typically induce hypothalamic hormones</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> to stimulate prolactin production.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serotonin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, if anything,<strong> increases prolactin release</strong>, but its role in antipsychotic-induced hyperprolactinemia is not the primary mechanism.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperprolactinemia can occur secondary to antipsychotic use due to blockage of D2 receptors in the <strong>tuberoinfundibular tract</strong>. Clinical features include galactorrhea, menstrual disturbances in females and gynecomastia, impotence in males. <strong>First choice for management of antipsychotic induced hyperprolactinemia is Aripiprazole. </strong>Second choices include dopamine agonists such as cabergoline, bromocriptine, amantadine etc, and metformin.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 168-169.</span></strong></span></span></p>",
      "correct_choice_id": 152506,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38188,
      "choices": [
        {
          "id": 152515,
          "text": "<p>De Clerambault's syndrome.</p>"
        },
        {
          "id": 152516,
          "text": "<p>Schizophrenia.</p>"
        },
        {
          "id": 152517,
          "text": "<p>Cocaine bugs.</p>"
        },
        {
          "id": 152518,
          "text": "<p>Delusional parasitosis.</p>"
        }
      ],
      "text": "<p>A 62-year-old woman presents to the psychiatry clinic referred from dermatologist with severe distress over a persistent belief that she is infested with bugs. She reports feeling them crawl on and under her skin, especially at night, and has multiple self-inflicted excoriated lesions on her arms and legs from trying to \"remove the bugs.\" She has seen multiple physicians, and all diagnostic evaluations, including skin biopsies, have returned negative for parasitic infestations. Her family is concerned about her increasing isolation, noting she has thrown out furniture and avoids family gatherings, fearing she might spread the \"infestation.\" Despite evidence to the contrary, she firmly believes in the presence of the parasites and has even brought in small lint balls from her bed, claiming they are the bugs. Which of the following is the most likely diagnosis?</p>",
      "unique_key": "Q3539034",
      "question_audio": null,
      "question_video": null,
      "map_id": 23884,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><strong>Ans. D) Delusional parasitosis.</strong></p><p><strong>&nbsp;</strong></p><p><strong>Option D:</strong></p><p>&nbsp;</p><p>The patient's fixed, false belief that she is infested with parasites despite medical evidence to the contrary is characteristic of delusional parasitosis (also known as Ekbom syndrome).&nbsp;</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A</strong>: De Clerambault's syndrome, also known as erotomania, is a delusional disorder where the individual believes that someone, typically of higher social status, is in love with them.</p><p>&nbsp;</p><p><strong>Option B</strong>: Schizophrenia is a chronic mental disorder characterized by delusions, hallucinations, disorganized speech, and/or disorganized or catatonic behavior, but the symptoms are broader than just a single delusion.</p><p>&nbsp;</p><p><strong>Option C</strong>: \"Cocaine bugs\" or \"magnan phenomenon\" refer to formication associated with cocaine use. Patients report tactile hallucinations (feeling of insects crawling under the skin). This sensation can lead the user to scratch or pick at their skin, causing lesions. However, this patient's presentation does not include other symptoms of cocaine use, and there's no evidence provided of drug abuse.</p><p>&nbsp;</p><p><strong>Educational Objective:&nbsp;</strong></p><p>&nbsp;</p><p>Delusional parasitosis, also known as Ekbom syndrome, is a psychiatric disorder in which patients have a delusion that they are infested by parasites or small creatures. They often present to dermatologists with \"evidence of parasites\" collected in a container (known as matchbox sign- Patients present with items they believe are parasites or worms. The items are usually stored in a small container, like a matchbox). Treatment includes antipsychotic medications, like pimozide or risperidone. While Willis Ekbom disease is another name for Restless less syndrome.</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: New Oxford Textbook of Psychiatry, 3rd edition, Page No 623-624.&nbsp;</span></p>",
      "correct_choice_id": 152518,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38189,
      "choices": [
        {
          "id": 152519,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Folie &agrave; deux</span></span></span></p>"
        },
        {
          "id": 152520,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Folie &agrave; trois</span></span></span></p>"
        },
        {
          "id": 152521,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bizarreness</span></span></span></p>"
        },
        {
          "id": 152522,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cotard&rsquo;s syndrome</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old male presents to the psychiatric clinic accompanied by his 60-year-old father. The father reports increasing concern regarding his son&#39;s behavior over the past few months. He explains that his son has become increasingly suspicious of their neighbors, often voicing concerns that they are plotting against him. He spends hours peeking through curtains and has even set up cameras. What deeply worries the father, however, is that over the past six weeks, the patient&#39;s 25-year-old sister has begun exhibiting similar behavior. She now avoids the neighbors, claiming they are plotting against her as well. Both siblings previously had good relationships with these neighbors and there&#39;s no concrete evidence to support their beliefs. Which of the following terms best describes this scenario?</span></span></p>",
      "unique_key": "Q6262426",
      "question_audio": null,
      "question_video": null,
      "map_id": 23885,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Folie &agrave; deux.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This term refers to a <strong>condition where a delusional belief</strong> <strong>is shared</strong> <strong>between two individuals</strong>. The <strong>primary individual has a delusional disorder</strong>, and a <strong>second person</strong>, usually in <strong>close relation to the first</strong>, comes to share the same delusional belief.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The situation described is one in which a delusional belief in one person (the 30-year-old male) appears to be transmitted to another close individual (his younger sister). This phenomenon is best captured by the term Folie &agrave; deux.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Folie &agrave; trois:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Similar to Folie &agrave; deux</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, but the delusional belief is shared between three close individuals.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Bizarreness:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bizarre delusions are <strong>scientifically impossible and culturally implausible.</strong> While the belief may be bizarre, this term alone doesn&#39;t account for the shared nature of the delusion between two people.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Cotard&rsquo;s syndrome:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>rare mental illness in which the affected person holds the delusional belief</strong> that they are <strong>dead, nonexistent,</strong> or have lost their blood or internal organs.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Shared psychotic disorder is characterized by <strong>spread of delusions from one person to another</strong>. The individual who has the <strong>delusion</strong> (the primary case) is typically the influential member of a close relationship with a more suggestible person (the secondary case) who also develops the delusion. When two people are involved, the term <strong>&ldquo;folie &agrave; deux&rdquo;</strong> is used. Occasionally more than two individuals are involved (known as <strong>folie &agrave; trois, folie &agrave; quatre</strong> etc). <strong>Treatment includes</strong> <strong>separating the individuals as part of the treatment strategy</strong>, which often leads to resolution of the shared delusional beliefs in the secondary individual. Treatment with antipsychotic medications can be beneficial for the primary affected individual.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 347.</span></strong></span></span></p>",
      "correct_choice_id": 152519,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38190,
      "choices": [
        {
          "id": 152523,
          "text": "<p>Delusional disorder</p>"
        },
        {
          "id": 152524,
          "text": "<p>Schizoaffective disorder</p>"
        },
        {
          "id": 152525,
          "text": "<p>Schizophreniform disorder</p>"
        },
        {
          "id": 152526,
          "text": "<p>Schizophrenia</p>"
        }
      ],
      "text": "<p>A 19-year-old college student contacts his parents, expressing intense fear that the Mafia is targeting him. He shares that for the past six weeks, he's only consumed canned beans, stating, \"they have eyes everywhere, and I can't risk it.\" He's certain that there are cameras placed by the Mafia in his hostel room to monitor him. Occasionally, he hears discussions about him, though no one is nearby. His roommate states that for the past 2 months the patient has been increasingly withdrawn and suspicious. Which of the following is the most likely diagnosis?</p>",
      "unique_key": "Q9953741",
      "question_audio": null,
      "question_video": null,
      "map_id": 23886,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><strong>Ans. C) Schizophreniform disorder</strong></p><p><strong>&nbsp;</strong></p><p><strong>Option C:</strong></p><p><strong>&nbsp;</strong></p><p>This student presents with symptoms of psychosis, including delusions (believing the Mafia is targeting him and has placed cameras in his dorm room) and auditory hallucinations (hearing discussions when no one is nearby). The duration of his symptoms is more than 1 month but less than 6 months, which is consistent with a ICD 10 diagnosis of schizophreniform disorder.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A</strong>: Delusional disorder is characterized by the presence of one or more delusions for at least 1 month without any other symptoms of psychosis. The presence of auditory hallucinations exceeds the criteria for this.</p><p>&nbsp;</p><p><strong>Option B</strong>: Schizoaffective disorder is the presence of symptoms of schizophrenia concurrent with major mood episodes. No mood symptoms are described in the vignette.</p><p>&nbsp;</p><p><strong>Option D</strong>: Schizophrenia has a similar presentation as schizophreniform disorder, but its symptoms must persist for at least 6 months. This student has been symptomatic for only 2 months.</p><p>&nbsp;</p><p><strong>Educational objective</strong>:&nbsp;</p><p>&nbsp;</p><p>As per ICD 10 Schizophreniform disorder is diagnosed when psychotic symptoms similar to schizophrenia are present for between 1-6 months while Schizophrenia requires symptoms to be present for at least 6 months</p><p>&nbsp;</p><p><strong>Ref</strong>: Kaplan &amp; Sadockâ€™s Synopsis of Psychiatry, 12th edition, Page No 343.</p>",
      "correct_choice_id": 152525,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38191,
      "choices": [
        {
          "id": 152527,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Echolalia&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></p>"
        },
        {
          "id": 152528,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Echopraxia</span></span></span></p>"
        },
        {
          "id": 152529,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perseveration</span></span></span></p>"
        },
        {
          "id": 152530,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Posturing</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old individual presents to the outpatient psychiatric clinic with a history of peculiar verbal responses. When asked introductory questions, the patient tends to immediately repeat the exact phrases spoken to them. The healthcare provider observes this pattern consistently throughout the interaction. Which of the following psychiatric phenomena is the patient most likely displaying?</span></span></p>",
      "unique_key": "Q1253947",
      "question_audio": null,
      "question_video": null,
      "map_id": 23887,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Echolalia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Echolalia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the <strong>involuntary repetition of words or phrases spoken by others</strong>. It is a phenomenon commonly associated with <strong>catatonia, autism spectrum disorder and Tourette syndrome</strong>. In this clinical scenario, the patient&#39;s repetition of the exact question asked by the healthcare provider is characteristic of echolalia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Echopraxia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the <strong>involuntary imitation of another person&#39;s movements</strong> and is not the correct answer since the patient is repeating words, not actions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Perseveration&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the <strong>repetition of the same response beyond the point of relevance</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Posturing&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">refers to the <strong>adoption of fixed, abnormal body positions for an extended period</strong> and is not relevant to the patient&rsquo;s presenting symptom of repeating spoken words.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Echolalia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the <strong>repetition of speech often seen in catatonia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 11th edition, Page No 345.</span></strong></span></span></p>",
      "correct_choice_id": 152527,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96435,
      "choices": [
        {
          "id": 383884,
          "text": "<p><span style=\"font-size:12.0pt;\">Lumateperone</span></p>"
        },
        {
          "id": 383885,
          "text": "<p><span style=\"font-size:12.0pt;\">Cobenfy (xanomeline + trospium)</span></p>"
        },
        {
          "id": 383886,
          "text": "<p><span style=\"font-size:12.0pt;\">Cariprazine</span></p>"
        },
        {
          "id": 383887,
          "text": "<p><span style=\"font-size:12.0pt;\">Trofinetide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs has been recently approved by the US Food and Drug Administration (FDA) for the management of schizophrenia and works primarily via a cholinergic (muscarinic) mechanism?</span></p>",
      "unique_key": "Q4616795",
      "question_audio": null,
      "question_video": null,
      "map_id": 37279,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Cobenfy (xanomeline + trospium)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cobenfy is the combination of the muscarinic M1/M4 receptor agonist xanomeline and the peripherally acting muscarinic antagonist trospium. It has been approved by the FDA for the treatment of schizophrenia in adults. This marks a novel mechanism of action among antipsychotics, shifting from the traditional dopamine D2 receptor blockade toward acetylcholine (cholinergic) pathways.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Option A. Lumateperone:</strong> Acts via serotonin and dopamine modulation, not a cholinergic mechanism.</span><br>&nbsp;</li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Cariprazine:</strong> A dopamine D2/D3 partial agonist; not newly approved for schizophrenia nor cholinergic.</span><br>&nbsp;</li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Trofinetide:</strong> Approved for Rett syndrome (a neurodevelopmental disorder), not for schizophrenia; mechanism unrelated to cholinergic M1/M4 receptors.</span><br>&nbsp;</li></ul><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The FDA approval of Cobenfy (xanomeline + trospium) illustrates a paradigm shift in schizophrenia treatment: targeting muscarinic (M1/M4) receptors instead of relying solely on dopamine-D2 receptor antagonism.</span></p>",
      "correct_choice_id": 383885,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}